(ROOT
  (S
    (NP (VBG Transforming) (NN growth))
    (VP (VBD factor-β-induced)
      (SBAR
        (S
          (NP (JJ regulatory) (NNP T) (NNS cells))
          (VP (VBP referee)
            (NP (JJ inflammatory)
              (CC and)
              (JJ autoimmune) (NNS diseases) (NN Abstract))
            (S
              (ADVP (RB Naturally))
              (VP (VBG occurring)
                (S
                  (NP (NNP CD4) (NNP +) (NNP CD25) (CD +) (JJ regulatory) (NN T) (NNS cells))
                  (VP (VB mediate)
                    (NP (JJ immune) (NN suppression)
                      (S
                        (VP (TO to)
                          (VP (VB limit)
                            (NP
                              (NP (NNS immunopathogenesis))
                              (VP (VBN associated)
                                (PP (IN with)
                                  (NP
                                    (NP (JJ chronic) (NN inflammation))
                                    (, ,)
                                    (NP (JJ persistent) (NNS infections))
                                    (CC and)
                                    (NP (JJ autoimmune) (NNS diseases))))))))))))))))))
    (. .)))

(ROOT
  (S
    (NP
      (NP (PRP$ Their) (NN mode))
      (PP (IN of)
        (NP (NN suppression))))
    (VP (VBZ is)
      (UCP
        (ADJP (JJ contact-dependent) (, ,) (JJ antigen-nonspecific))
        (CC and)
        (VP (VBZ involves)
          (NP (DT a) (JJ nonredundant) (NN contribution))
          (PP (IN from)
            (NP
              (NP (DT the) (JJ cytokine) (JJ transforming) (NN growth) (NN factor))
              (PRN (-LRB- -LRB-)
                (NP (NNP TGF))
                (-RRB- -RRB-))
              (: -)
              (NP (NN β)))))))
    (. .)))

(ROOT
  (S
    (CONJP (RB Not) (JJ only))
    (SINV (MD can)
      (NP (NNP TGF-β))
      (VP (VB mediate)
        (NP
          (NP (NN cell))
          (: --)
          (NP
            (NP (NN cell) (NN suppression))
            (PP (IN between)
              (NP
                (NP (DT the) (JJ regulatory) (NNP T) (NNS cells))
                (CC and)
                (NP (NNP CD4) (NNP +) (NNP CD25)))))
          (: -)
          (CC or)
          (NP (CD CD8) (NNP +) (NNP T) (NNS cells)))))
    (, ,)
    (CC but)
    (S
      (NP (JJ new) (NN evidence))
      (ADVP (RB also))
      (VP (VBZ reveals)
        (NP (PRP$ its) (NN role))
        (PP (IN in)
          (NP
            (NP (DT the) (NN conversion))
            (PP (IN of)
              (NP
                (NP (NNP CD4) (NNP +) (NNP CD25))
                (: -)
                (NP
                  (NP (NNP T))
                  (NP (NNS cells))
                  (, ,)
                  (ADVP (RB together)
                    (PP (IN with)
                      (NP (NNP TCR) (NN antigen) (NN stimulation)))))))))
        (, ,)
        (PP (IN into)
          (NP (DT the) (JJ regulatory) (NN phenotype)))))
    (. .)))

(ROOT
  (S
    (NP
      (NP (NNP Elemental))
      (PP (TO to)
        (NP (DT this) (NN conversion) (NN process))))
    (VP (VBZ is)
      (NP
        (NP (NN induction))
        (PP (IN of)
          (NP
            (NP (NN expression))
            (PP (IN of)
              (NP
                (NP (DT the) (JJ forkhead) (NN transcription) (NN factor))
                (, ,)
                (NP (NNS Foxp3))))))))
    (. .)))

(ROOT
  (S
    (NP
      (NP (DT This) (JJ context-dependent) (NN coercion))
      (PP (IN of)
        (S
          (VP (VBG naive)
            (NP (CD CD4) (NNP +) (NNP T) (NNS cells))
            (PP (IN into)
              (NP
                (NP (DT a) (JJ powerful) (NN subset))
                (PP (IN of)
                  (NP (JJ regulatory) (NNS cells)))))))))
    (VP (VBZ provides)
      (NP (DT a) (NN window))
      (PP (IN into)
        (NP
          (NP (JJ potential) (NN manipulation))
          (PP (IN of)
            (NP (DT these) (NNS cells)))))
      (S
        (VP (TO to)
          (VP (VB orchestrate)
            (NP (JJ therapeutic) (NN intervention))
            (PP (IN in)
              (NP
                (NP
                  (NP (NNS diseases))
                  (VP (VBN characterized)
                    (PP (IN by)
                      (NP (JJ inadequate) (NN suppression)))))
                (, ,)
                (CONJP (RB as) (RB well) (IN as))
                (NP
                  (NP (DT a) (JJ promising) (NN means))
                  (PP (IN of)
                    (NP (JJ controlling) (JJ pathologic) (NNS situations)))
                  (SBAR
                    (WHPP (IN in)
                      (WHNP (WDT which)))
                    (S
                      (NP (JJ excessive) (NN suppression))
                      (VP (VBZ dominates)))))))))))
    (. .)))

(ROOT
  (S
    (NP (NNP Introduction) (NNP Autoimmune) (NNS diseases))
    (VP (VBP are)
      (VP (VBN characterized)
        (PP (IN by)
          (NP
            (NP (DT a) (NN loss))
            (PP (IN of)
              (NP
                (NP (NN regulation))
                (PP (IN of)
                  (NP
                    (NP (NNP T) (NN cell) (NN growth))
                    (CC and)
                    (NP (NN activation))))))))
        (, ,)
        (PP (IN with)
          (NP (JJ resultant) (NN overexuberant) (NN inflammation)
            (CC and)
            (NN tissue) (NN destruction)))))
    (. .)))

(ROOT
  (S
    (SBAR (IN Although)
      (S
        (NP
          (NP (NNP T) (NN cell) (NNS responses))
          (PP (TO to)
            (NP (JJ foreign) (NNS antigens))))
        (VP (VBP are)
          (ADJP (JJ essential)
            (PP (TO to)
              (NP (PRP$ our) (NN protection))))
          (PP (IN from)
            (NP
              (NP (DT a) (NN plethora))
              (PP (IN of)
                (NP
                  (ADJP (RB potentially) (JJ pathogenic))
                  (NNS agents)
                  (CC and)
                  (NNS microbes))))))))
    (, ,)
    (NP
      (NP (NNP T) (NN cell) (NNS responses))
      (PP (TO to)
        (NP (NN self) (NNS antigens))))
    (VP (MD can)
      (VP (VB be)
        (ADJP (RB overtly) (JJ deleterious))))
    (. .)))

(ROOT
  (S
    (SBAR (IN As)
      (S
        (NP
          (NP (DT the) (JJ signaling) (NNS pathways))
          (VP (VBN associated)
            (PP (IN with)
              (NP (NNP T) (NN cell) (NN activation)))))
        (VP (VBP continue)
          (S
            (VP (TO to)
              (VP (VB be)
                (VP (VBN illuminated))))))))
    (, ,)
    (NP (EX there))
    (VP (VBZ is)
      (ADVP (RB also))
      (NP
        (NP (DT an) (VBG emerging) (NN excitement))
        (PP (IN about)
          (S
            (ADVP (RB naturally))
            (VP (VBG occurring)
              (NP
                (NP (VBG opposing) (NNS forces))
                (SBAR
                  (WHNP (WDT that))
                  (S
                    (VP (MD can)
                      (VP (VB exert)
                        (NP (NN control))
                        (PP (IN over)
                          (NP (JJ antigen-activated) (NNP T) (NNS cells)))))))))))
        (S
          (VP (TO to)
            (VP (VB prevent)
              (NP (NN reactivity))
              (PP (TO to)
                (NP (NN self))))))))
    (. .)))

(ROOT
  (S
    (NP
      (NP (NNP Suppressor) (NNP T) (NNS cells))
      (, ,)
      (VP (VBN implicated)
        (PP (IN in)
          (NP (DT this) (JJ regulatory) (NN process) (NNS decades)))
        (ADVP (IN ago)))
      (, ,))
    (VP
      (VP (VBD fell)
        (PP (IN into)
          (NP (JJ ill) (NN repute))))
      (CC but)
      (VP (VBP have)
        (ADVP (RB recently))
        (VP (VBN re-emerged)
          (PP
            (CONJP (RB not) (JJ only))
            (PP (IN as)
              (NP (DT a) (JJ real) (NN population)))
            (CC but)
            (PP (IN as)
              (NP
                (NP
                  (NP (DT a) (NN population))
                  (ADJP (JJ crucial)
                    (PP (TO to)
                      (NP (JJ immune) (NNS homeostasis)))))
                (, ,)
                (NP
                  (NP (NN maintenance))
                  (PP (IN of)
                    (NP (NN tolerance))))
                (, ,)
                (CC and)
                (NP
                  (NP (NN prevention))
                  (PP (IN of)
                    (NP
                      (NP (DT the) (NN onset))
                      (PP (IN of)
                        (NP (JJ autoimmune) (NN disease))))))))))))
    (. .)))

(ROOT
  (S
    (NP (PRP$ Their) (NN existence))
    (VP (VBZ is)
      (ADJP
        (ADJP (RB no) (JJR longer)
          (PP (IN in)
            (NP (NN question))))
        (, ,)
        (CC but)
        (ADJP (JJ true)
          (PP (TO to)
            (NP (PRP$ their) (NN history)))))
      (SBAR
        (S
          (NP
            (NP (DT these) (NNS cells))
            (, ,)
            (NP (PRP$ their) (NN origin))
            (, ,)
            (NP (NN generation))
            (, ,)
            (CC and)
            (NP
              (NP (NNS mechanisms))
              (PP (IN of)
                (NP (NN action)))))
          (VP (VBP have)
            (VP (VBN generated)
              (NP (JJ considerable) (NN controversy)))))))
    (. .)))

(ROOT
  (S
    (NP
      (NP (NNP Recognition))
      (PP (IN of)
        (NP
          (NP (DT the) (JJ potential) (NN impact))
          (PP (IN of)
            (NP
              (NP (DT these) (NNS cells))
              (PP (IN in)
                (NP (JJ clinical) (JJ cellular) (NN therapy))))))))
    (VP (VBZ has)
      (VP (VBN driven)
        (NP
          (NP (DT a) (JJ rapid) (NN expansion))
          (PP (IN of)
            (NP (DT the) (NN field))))
        (SBAR (IN in) (NN order)
          (S
            (VP (TO to)
              (VP (VB understand)
                (CC and)
                (VB manipulate)
                (NP (DT the) (JJ regulatory) (NNP T) (NN cell) (NN population))
                (S
                  (VP (TO to)
                    (VP (VB devise)
                      (S
                        (NP (NNS strategies))
                        (VP (TO to)
                          (VP (VB control)
                            (NP
                              (NP (JJ autoimmunity) (, ,) (JJ transplantation) (NN tolerance) (, ,) (NN tumor) (NN immunity) (, ,) (NN allergy)
                                (CC and)
                                (JJ infectious) (NNS diseases))
                              (, ,) (RB particularly)
                              (NP (NN HIV)))))))))))))))
    (. .)))

(ROOT
  (S
    (NP
      (NP (CD One))
      (PP (IN of)
        (NP
          (NP (DT the) (JJS most))
          (VP
            (ADVP (RB intensely))
            (VBN studied)
            (PP (IN of)
              (NP
                (NP (DT the) (JJ heterogeneous) (NN family))
                (PP (IN of)
                  (NP (JJ regulatory) (NNP T) (NNS cells)))))))))
    (VP (VBZ is)
      (NP
        (NP (DT a) (NN population))
        (PP (IN of)
          (S
            (NP (NNP CD4) (NNP +) (NNP T) (NNS cells))
            (ADVP (RB constitutively))
            (VP
              (VP (VBG expressing)
                (NP
                  (NP (NNP CD25))
                  (PRN (-LRB- -LRB-)
                    (NP (NNP IL-2Rα))
                    (-RRB- -RRB-))
                  (, ,)
                  (VP (VBN found)
                    (PP
                      (PP (IN in)
                        (NP (NNS thymus)))
                      (CC and)
                      (PP (IN in)
                        (NP (JJ peripheral) (JJ lymphoid) (NNS organs)))))
                  (, ,)))
              (CC and)
              (VP (VBG comprising)
                (NP
                  (NP
                    (QP (CD 5) (TO to) (CD 10))
                    (NN %))
                  (PP (IN of)
                    (NP (DT the) (JJ total) (NNP CD4) (NNP +) (NNP T) (NNS cells))))
                (PP (IN in)
                  (NP (NNS mice)
                    (CC and)
                    (NNS humans)))
                (S
                  (VP (VBG -LSB-)
                    (NP (CD 1-5) (NNS -RSB-))))))))))
    (. .)))

(ROOT
  (S
    (PP (IN On)
      (NP
        (NP (DT the) (NN basis))
        (PP (IN of)
          (NP (PRP$ their)
            (ADJP (JJ unique) (JJ functional))
            (NNS properties)))))
    (, ,)
    (NP
      (NP (DT this)
        (ADJP (JJ small)
          (CC but)
          (JJ powerful))
        (NN population))
      (PP (IN of)
        (NP (NNP T) (NNS cells))))
    (VP (VBZ has)
      (VP (VBN been)
        (VP (VBN dubbed)
          (NP
            (NP (CD CD4)
              (ADJP
                (QP (CD +) (CD CD25)))
              (JJ +) (JJ regulatory) (NN T) (NNS cells))
            (PRN (-LRB- -LRB-)
              (NP (NNP Treg))
              (-RRB- -RRB-))))))
    (. .)))

(ROOT
  (S
    (PP (IN In)
      (NP
        (NP (NN contrast))
        (PP (TO to)
          (NP
            (NP (NNP CD4) (NNP +) (NNP CD25))
            (: -)
            (NP
              (NP (NNP T) (NNS cells))
              (, ,)
              (NP (RB freshly) (VBN isolated) (NNP CD4) (NNP +) (NNP CD25)))))))
    (NP (NNP +) (NNP Treg))
    (VP (VBP are)
      (ADJP (JJ anergic)
        (S
          (VP (TO to)
            (VP (VB TCR)
              (NP (NN stimulation))
              (PP (IN in)
                (ADJP (NN vitro))))))))
    (. .)))

(ROOT
  (S
    (ADVP (RB However))
    (, ,)
    (S
      (VP
        (ADVP (RB once))
        (VBN activated)))
    (, ,)
    (NP (DT these) (NN Treg))
    (VP (VBP are)
      (ADJP (JJ robust)
        (SBAR
          (S
            (VP
              (VP (VBZ suppressors))
              (CC and)
              (VP (MD can)
                (VP (VB mediate)
                  (NP
                    (NP (DT the) (NN inhibition))
                    (PP (IN of)
                      (NP (NNP CD4) (NNP +) (NNP CD25)))
                    (PRN (: -)
                      (NP
                        (NP (NN responder) (NN T) (NNS cells))
                        (PP (IN by)
                          (NP
                            (NP (NNS means))
                            (PP (IN of)
                              (NP
                                (NP (DT a) (JJ cell-contact-dependent) (NN mechanism))
                                (VP (VBG involving)
                                  (S
                                    (VP (VBG transforming)
                                      (NP
                                        (NP (NN growth) (NN factor))
                                        (PRN (-LRB- -LRB-)
                                          (NP (NNP TGF))
                                          (-RRB- -RRB-)))))))))))
                      (: -))
                    (NP
                      (NP (NNP β) (NNP -LSB-) (NNP 6-9) (NNP -RSB-))
                      (PRN (-LRB- -LRB-)
                        (NP
                          (QP (CD Fig.) (CD 1)))
                        (-RRB- -RRB-)))))))))))
    (. .)))

(ROOT
  (S
    (SBAR (IN Although)
      (S
        (NP
          (NP (DT the) (NN role))
          (PP (IN of)
            (NP (NNP TGF-β))))
        (VP (VBZ has) (RB not)
          (ADVP (RB yet))
          (VP (VBN been)
            (VP
              (ADVP (RB universally))
              (VBN accepted)
              (NP
                (QP (CD -LSB-) (CD 10,11))
                (NNS -RSB-)))))))
    (, ,)
    (NP
      (NP (DT the) (NN preponderance))
      (PP (IN of)
        (NP (NN evidence))))
    (VP (VBZ has)
      (VP (VBN solidified)
        (NP (DT a) (NN contribution))
        (PP (IN from)
          (NP
            (ADJP (JJ TGF-β)
              (PP (IN in)
                (NP (DT the) (JJ regulatory) (NN process))))
            (JJ -LSB-) (JJ 6-8) (CD ,12) (JJ -15) (NNS -RSB-)))))
    (. .)))

(ROOT
  (S
    (NP
      (NP (DT The) (NN essentiality))
      (PP (IN of)
        (NP
          (NP (DT this) (JJ endogenous) (NN population))
          (PP (IN in)
            (S
              (VP (VBG protecting)
                (NP (DT the) (NN host))
                (PP (IN from)
                  (NP (JJ disproportionate) (NNP T) (NN cell) (NN activation)
                    (CC and)
                    (NN autoreactive) (NN effector) (NNS cells)))))))))
    (VP (VBZ is)
      (VP (VBN underscored)
        (PP (DT both)
          (PP (IN in)
            (NP (JJ experimental) (NNS models)))
          (CC and)
          (PP (IN in)
            (NP (NNS humans))))
        (PP (IN in)
          (SBAR
            (WHNP (WDT which))
            (S
              (NP
                (NP (DT the) (NNS numbers) (NN and/or) (NN function))
                (PP (IN of)
                  (NP (NNP Treg))))
              (VP (VBP are)
                (VP (VBN compromised)
                  (S
                    (VP (VBG -LSB-)
                      (NP (CD 6,10,16-20) (NNS -RSB-)))))))))))
    (. .)))

(ROOT
  (S
    (PP (IN In)
      (NP (NNS mice)))
    (, ,)
    (NP
      (NP (NN depletion))
      (PP (IN of)
        (NP
          (NP (NNP CD4) (NNP +) (NNP CD25) (NNP +) (NNP T) (NNS cells))
          (PP (IN by)
            (NP
              (NP (NN neonatal))
              (PRN (-LRB- -LRB-)
                (NP (NN day) (CD 3))
                (-RRB- -RRB-)))))))
    (ADVP (RB thymectomy))
    (VP (VBZ leads)
      (PP (TO to)
        (NP
          (NP (JJ spontaneous) (NN development))
          (PP (IN of)
            (NP (JJ organ-specific) (JJ autoimmune) (NNS diseases)))
          (, ,)
          (PP (VBG including)
            (NP
              (NP (JJ autoimmune) (NNS thyroiditis))
              (, ,)
              (NP (NNS gastritis))
              (, ,)
              (CC and)
              (NP (NNP wasting) (NNP -LSB-) (CD 19) (NNP -RSB-))))
          (, ,)
          (SBAR
            (WHNP (WDT which))
            (S
              (VP (MD can)
                (VP (VB be)
                  (VP (VBN reversed)
                    (PP (IN by)
                      (NP
                        (NP (JJ adoptive) (NN transfer))
                        (PP (IN of)
                          (NP (NNP Treg) (NNP -LSB-) (CD 21) (NNS -RSB-)))))))))))))
    (. .)))

(ROOT
  (SINV
    (VP (VBG Treg))
    (VP (VBP are)
      (ADJP (JJ pivotal)
        (PP (IN in)
          (NP
            (NP (DT the) (NN protection))
            (PP (IN of)
              (NP (JJ lymphopenic) (NNS mice))))))
      (PP (IN from)
        (NP
          (NP (JJ induced) (JJ inflammatory) (NN bowel) (NN disease))
          (, ,)
          (NP (JJ experimental) (JJ autoimmune) (NNS encephalomyelitis))
          (, ,)
          (NP (NN diabetes))
          (, ,)
          (CC and)
          (NP (NN allergy) (NNS -LSB-)))))
    (NP (CD 16,18,22) (NN -RSB-))
    (. .)))

(ROOT
  (S
    (PP (IN In)
      (NP (JJ infectious) (NNS models)))
    (, ,)
    (NP (NNP Treg))
    (ADVP (RB also))
    (VP (VBP influence)
      (NP
        (NP (DT the) (JJ effector) (JJ immune) (NN response))
        (, ,)
        (SBAR (IN as)
          (S
            (VP (VBZ is)
              (ADJP (JJ evident)
                (PP (IN in)
                  (NP (NNP Leishmania) (JJ major) (NN infection))))
              (S
                (VP (VBG -LSB-)
                  (NP (CD 20) (NNS -RSB-)))))))))
    (. .)))

(ROOT
  (S
    (NP (DT Both)
      (ADJP (JJ innate)
        (CC and)
        (JJ adaptive))
      (JJ immune) (NNS responses))
    (VP (VBP are)
      (ADJP (JJ subject)
        (PP (TO to)
          (S
            (VP (VBG Treg)
              (NP (NN control)))))))
    (. .)))

(ROOT
  (S
    (S
      (VP (VBG Triggering)
        (PP (IN of)
          (NP (JJ dendritic) (NNS cells)))
        (PP (IN by)
          (NP
            (NP (JJ Toll-like) (NN receptor) (NNS ligands))
            (VP (VBN expressed)
              (PP (IN by)
                (S
                  (VP (VBG invading)
                    (NP (NNS pathogens))))))))))
    (VP (VBZ leads)
      (PP (TO to)
        (NP
          (NP (DT the) (NN production))
          (PP (IN of)
            (NP (JJ soluble) (NNS factors)))
          (, ,)
          (PP (VBG including)
            (NP
              (NP (NN IL-6))
              (, ,)
              (SBAR
                (WHNP (WDT that))
                (S
                  (VP (MD may)
                    (VP (VB render)
                      (S
                        (NP (NN effector) (NNS cells))
                        (ADJP (JJ refractory)
                          (PP (TO to)
                            (NP (JJ regulatory) (NN activity))))
                        (S
                          (VP (VBG -LSB-)
                            (NP (CD 23) (NNS -RSB-))))))))))))))
    (. .)))

(ROOT
  (S
    (ADVP (RB Moreover))
    (, ,)
    (NP (VBN activated) (JJ dendritic) (NNS cells))
    (VP (VBP produce)
      (NP
        (NP (NNP TGF-β))
        (, ,)
        (SBAR
          (WHNP (WDT which))
          (S
            (VP (MD may)
              (ADVP (RBR further))
              (VP (VB influence)
                (NP
                  (NP (DT the) (NN development))
                  (PP (IN of)
                    (NP (NNP Treg) (NNP -LSB-) (NNP 24) (NNP -RSB-))))))))))
    (. .)))

(ROOT
  (S
    (PP (IN By)
      (NP (JJ such) (NN intersecting) (NNS pathways)))
    (, ,)
    (NP
      (NP (DT the) (NN innate))
      (CC and)
      (NP
        (NP (JJ regulatory) (NNS arms))
        (PP (IN of)
          (NP (DT the) (JJ immune) (NN system)))))
    (VP (VBP have)
      (NP (DT the) (NN capacity)
        (S
          (VP (TO to)
            (VP (VB exert)
              (NP
                (NP (JJ sufficient) (NN control))
                (PP (IN over)
                  (NP (DT each) (JJ other))))
              (S
                (VP (TO to)
                  (VP (VB enable)
                    (NP (NN effector) (NNS cells))
                    (S
                      (VP (TO to)
                        (VP (VB mount)
                          (NP (JJ efficient) (JJ immune) (NNS responses))
                          (PP (IN with)
                            (NP (JJ minimal) (NN pathology))))))))))))))
    (. .)))

(ROOT
  (S
    (PP (IN In)
      (NP
        (NP (JJ human) (NNS infectious))
        (, ,)
        (NP (NN neoplastic))
        (, ,)
        (CC and)
        (NP (JJ autoimmune) (NNS diseases))))
    (, ,)
    (NP (NNP Treg) (NNS activities))
    (ADVP (RB often))
    (VP (VBP mirror)
      (NP
        (NP (DT those))
        (PP (IN in)
          (NP (JJ murine) (NNS systems)))))
    (. .)))

(ROOT
  (S
    (NP
      (NP (NNS Numbers))
      (PP (IN of)
        (NP (NNP Treg))))
    (VP (VBP are)
      (ADVP (RB reportedly))
      (VP (VBN reduced)
        (PP (IN in)
          (NP
            (NP (JJ human) (JJ autoimmune) (NNS diseases))
            (VP (VBG -LSB-)
              (NP (CD 17,25) (NNS -RSB-)))))
        (, ,)
        (SBAR (IN although)
          (S
            (NP
              (NP (PRP$ their) (NN significance))
              (PP (IN in)
                (NP
                  (NP (DT the) (NN evolution))
                  (PP (IN of)
                    (NP (NNS immunopathogenesis))))))
            (VP (VBZ remains)
              (NP
                (NP (DT an) (NN area))
                (PP (IN of)
                  (NP (VBN continued) (NN exploration)))))))))
    (. .)))

(ROOT
  (S
    (ADVP (RB Moreover))
    (, ,)
    (NP
      (NP (VBD increased) (NNP CD4) (NNP +) (NNP CD25) (NNP +))
      (SBAR
        (S
          (NP (JJ regulatory) (NNP T) (NNS cells))
          (VP (VBP have)
            (VP (VBN been)
              (VP (VBN reported)
                (PP (IN in)
                  (S
                    (NP (NNP HIV-1))
                    (ADVP (RB immunodeficiency))
                    (VP (VBG -LSB-)
                      (NP
                        (NP
                          (QP (CD 26) (CD -RSB-)))
                        (, ,)
                        (CC and)
                        (NP
                          (PP (IN in)
                            (NP (NN lung) (NN cancer) (NNS patients)))
                          (NP (DT the) (VBN increased) (NNS numbers))
                          (PP (IN of)
                            (NP (NNP CD4) (NNP +) (NNP CD25) (NNP +) (JJ regulatory) (NN T) (NNS cells))))))))))))))
    (ADVP (RB directly))
    (VP (VBP inhibit)
      (SBAR
        (S
          (NP (NNS autologous))
          (VP (VBP T)
            (NP (NN cell) (NN proliferation) (NNP -LSB-) (CD 27) (NNP -RSB-))))))
    (. .)))

(ROOT
  (S
    (ADVP (RB Thus))
    (, ,)
    (NP
      (NP (DT this)
        (ADJP (JJ unique)
          (CC and)
          (JJ persuasive))
        (NN population))
      (PP (IN of)
        (NP (JJ regulatory) (NNP T) (NNS cells))))
    (VP (VBZ has)
      (NP
        (NP (DT a) (JJ crucial) (NN role))
        (PP (IN in)
          (NP
            (NP (DT the) (NN maintenance))
            (PP (IN of)
              (NP (NN tolerance)
                (CC and)
                (JJ immune) (NNS homeostasis))))))
      (PP (IN through)
        (NP (JJ immune) (NN suppression))))
    (. .)))

(ROOT
  (S
    (NP
      (NP (NNP Mechanism))
      (PP (IN of)
        (NP (NNP Treg) (NNP suppression) (NNP Treg))))
    (VP (VBP are) (DT both)
      (ADJP
        (ADJP
          (ADJP (JJ anergic))
          (PRN (, ,)
            (PP
              (ADVP (IN at) (JJS least))
              (IN in)
              (ADJP (NN vitro)))
            (, ,)))
        (CC and)
        (ADJP (JJ immunosuppressive))))
    (. .)))

(ROOT
  (S
    (NP
      (NP (DT The) (NN absence))
      (PP (IN of)
        (NP
          (NP (JJ Treg) (NNS results))
          (PP (IN in)
            (NP
              (NP
                (NP (DT the) (NN breakdown))
                (PP (IN of)
                  (NP (NN tolerance))))
              (CC and)
              (NP
                (NP (DT the) (NN development))
                (PP (IN of)
                  (NP (JJ autoimmune) (NNS diseases)))))))))
    (VP (VBZ -LSB-)
      (NP (CD 28) (NNS -RSB-)))
    (. .)))

(ROOT
  (S
    (NP
      (NP (PRP$ Our) (NN understanding))
      (PP (IN of)
        (NP
          (NP (DT the)
            (ADJP (JJ functional))
            (NN domain))
          (PP (IN of)
            (NP (DT these) (NNS cells))))))
    (VP (VBZ has)
      (ADVP (RB rapidly))
      (VP (VBN advanced)
        (PP (IN through)
          (NP (NN cell) (NN culture) (NNS experiments)))))
    (. .)))

(ROOT
  (S
    (PP (IN In)
      (ADJP (NN vitro)))
    (, ,)
    (NP
      (NP (DT the) (NN ability))
      (PP (IN of)
        (NP
          (NP (NNP CD4) (NNP +) (NNP CD25) (NNP +) (NNP Treg))
          (PP (TO to)
            (NP (NNP suppress) (NNP responder) (NNP T) (NN cell) (NN proliferation)
              (CC and)
              (NN cytokine) (NN production))))))
    (VP
      (VP (VBZ requires)
        (NP (PRP$ their) (NN activation)))
      (, ,)
      (VP (VBZ is)
        (ADJP (JJ dependent)
          (PP (IN on)
            (NP (NN cell) (NN contact)))))
      (, ,)
      (CC and)
      (VP (VBZ is)
        (VP (VBG antigen)
          (NP (JJ nonspecific) (NNP -LSB-) (CD 1,6,10) (NNS -RSB-)))))
    (. .)))

(ROOT
  (S
    (PP (IN After)
      (NP
        (NP (NNS years))
        (PP (IN of)
          (S
            (VP (VBG searching)
              (PP (IN for)
                (NP
                  (NP (DT the)
                    (ADJP (JJ elusive))
                    (NN mediator))
                  (PRN (-LRB- -LRB-) (PRP s) (-RRB- -RRB-))
                  (PP (IN of)
                    (NP
                      (NP (NN suppression))
                      (ADJP (JJ consistent)
                        (PP (IN with)
                          (NP (DT the) (JJ accepted) (JJ cell-contact-dependent) (NN mechanism)))))))))))))
    (, ,)
    (NP (JJ membrane-associated) (NNS TGF-β))
    (VP (VBD was)
      (VP (VBN identified)
        (PP (IN as)
          (NP
            (NP (DT a) (JJ pivotal) (NN perpetrator))
            (VP (VBG -LSB-)
              (NP (CD 6,7,14) (NNS -RSB-)))))))
    (. .)))

(ROOT
  (S
    (S
      (PP (IN In)
        (NP (DT this) (NN regard)))
      (, ,)
      (NP (NN latent) (NNS TGF-β))
      (VP (VBD was)
        (ADVP (RB first))
        (VP (VBN reported)
          (S
            (VP (TO to)
              (VP (VB be)
                (ADJP (RB constitutively) (JJ present)
                  (PP (IN on)
                    (NP
                      (NP (DT the) (NN surface))
                      (PP (IN of)
                        (S
                          (VP (VBG Treg)
                            (NP
                              (QP (CD -LSB-) (CD 6,7))
                              (NNS -RSB-))))))))))))))
    (: ;)
    (S
      (ADVP (RB subsequently))
      (, ,)
      (NP (JJ active) (NNS TGF-β))
      (VP (VBD was)
        (VP (VBN identified)
          (NP
            (QP (CD -LSB-) (CD 6,8,14))
            (NNS -RSB-)))))
    (. .)))

(ROOT
  (SINV
    (PP (IN In)
      (NP
        (NP (JJ vitro) (NN stimulation))
        (PP (IN with)
          (NP (JJ anti-CD3)
            (CC and)
            (JJ antigen-presenting) (NNS cells)))))
    (VP
      (PRN (-LRB- -LRB-)
        (NP (NNP APCs))
        (-RRB- -RRB-))
      (VBZ enhances)
      (NP
        (NP (JJ membrane-bound) (JJ active) (NNS TGF-β))
        (, ,)
        (SBAR
          (WHNP (WDT which))
          (S
            (VP (VBZ is)
              (ADJP (JJ consistent)
                (PP (IN with)
                  (NP (DT the) (NN requirement))))
              (SBAR (IN that)
                (S
                  (NP (NNP Treg) (NNP activation))
                  (VP (VBZ promotes)
                    (NP (PRP$ their) (JJ suppressive) (JJ potential) (NN -LSB-))))))))))
    (NP
      (NP (CD 6,13) (NNS -RSB-))
      (PRN (-LRB- -LRB-)
        (NP
          (NP (NNP W) (NNP Chen))
          (, ,)
          (NP (JJ unpublished) (NNS data)))
        (-RRB- -RRB-)))
    (. .)))

(ROOT
  (S
    (NP
      (NP (NNP Blockade))
      (PP (IN of)
        (NP
          (NP (JJ cell-surface) (NNS TGF-β))
          (PP (IN with)
            (NP (JJ neutralizing) (NNS antibodies))))))
    (, ,)
    (PP
      (PP (IN with)
        (NP (JJ soluble) (JJ TGF-β) (NN receptor)))
      (, ,)
      (CC or)
      (PP (IN with)
        (VP
          (NP (JJ recombinant) (JJ latency-associated) (NN peptide) (NNS disrupts))
          (NP
            (NP (DT the) (NN ability))
            (PP (IN of)
              (NP (DT these) (NNS cells))))
          (S
            (VP (TO to)
              (VP (VB block)
                (NP (NN responder) (NN T) (NN cell) (NN proliferation))))))))
    (, ,)
    (NP
      (NP (VBG confirming) (NNS TGF-β))
      (PP (IN as)
        (NP
          (NP (DT an) (NN instrument))
          (PP (IN of)
            (NP (NN suppression))))))
    (VP (VBZ -LSB-)
      (NP (CD 6-8) (CD ,12,13,15,29) (NNS -RSB-)))
    (. .)))

(ROOT
  (SINV
    (ADJP (RB Still) (VBG missing))
    (VP (VBD was))
    (NP
      (NP
        (NP (DT the) (JJ connecting) (NN link))
        (SBAR
          (WHPP (IN by)
            (WHNP (WDT which)))
          (S
            (NP (JJ membrane-bound) (NNS TGF-β))
            (VP (MD could)
              (VP (VB interact)
                (PP (IN with)
                  (NP (DT the) (NNP CD4) (NNP +) (NNP CD25))))))))
      (: -)
      (NP (NN responder) (NNS cells)))
    (. .)))

(ROOT
  (S
    (ADVP (RB Recently))
    (, ,)
    (NP
      (NP (JJ TGF-β) (NN receptor) (NN type) (NNP II))
      (PRN (-LRB- -LRB-)
        (NP (NNP TβRII))
        (-RRB- -RRB-)))
    (VP (VBD was)
      (VP (VBN detected)
        (PP (IN at)
          (NP
            (NP (JJ elevated) (NNS levels))
            (PP (IN on)
              (NP (JJ responder) (NNP T) (NNS cells)))))
        (SBAR (IN once)
          (S
            (NP (PRP they))
            (VP (VBD were)
              (VP (VBN activated)
                (PP (IN through)
                  (NP (PRP$ their) (NN TCR)))
                (, ,)
                (S
                  (ADVP (RB thereby))
                  (VP (VBG providing)
                    (NP (DT the) (JJ molecular) (NN bridge))
                    (PP (IN by)
                      (SBAR
                        (WHNP (WDT which))
                        (S
                          (NP
                            (NP (NNP TGF-β))
                            (PP (IN on)
                              (NP
                                (NP (DT the) (NNP Treg) (NNS orchestrates) (NN suppression))
                                (PP (IN of)
                                  (NP (DT the) (NN responder) (NNS cells))))))
                          (VP (VBZ -LSB-)
                            (NP (CD 6,8,12) (NNS -RSB-))))))))))))))
    (. .)))

(ROOT
  (S
    (NP (JJ TGF-β) (NNS signaling)
      (CC and)
      (NN regulation) (NNS TGF-β))
    (VP (VBZ is)
      (NP
        (NP (DT a) (JJ potent) (NN cytokine)
          (CC and)
          (NN growth) (NN factor))
        (SBAR (WP$ whose)
          (S
            (NP (JJ biological) (NN activity))
            (VP (VBZ is)
              (ADVP (RB primarily))
              (VP (VBN regulated)
                (NP (JJ post-translationally) (NNP -LSB-) (CD 30) (NNS -RSB-))
                (, ,)
                (SBAR
                  (SBAR (IN because)
                    (S
                      (NP (PRP it))
                      (VP (VBZ is)
                        (VP (VBN transcribed)
                          (CC and)
                          (VBN translated)
                          (PP (IN as)
                            (NP
                              (NP (DT a) (JJ small) (NN latent) (NN complex))
                              (VP (VBN composed)
                                (PP
                                  (CONJP (RB not) (JJ only))
                                  (PP (IN of)
                                    (NP (JJ active) (NNS TGF-β)))
                                  (, ,)
                                  (CONJP (CC but)
                                    (RB also))
                                  (PP (IN of)
                                    (NP
                                      (NP (DT a) (JJ latency-associated) (NN peptide))
                                      (PRN (-LRB- -LRB-)
                                        (NP (NNP LAP))
                                        (-RRB- -RRB-))
                                      (SBAR
                                        (WHPP (TO to)
                                          (WHNP (WDT which)))
                                        (S
                                          (NP (PRP it))
                                          (VP (VBZ is)
                                            (ADJP (RB noncovalently) (VBN bound)))))))))))))))
                  (CC and)
                  (SBAR
                    (WHNP (WDT which))
                    (S
                      (VP (VBZ prevents)
                        (NP (PRP$ its) (NN interaction))
                        (PP (IN with)
                          (NP
                            (NP (PRP$ its) (JJ specific) (NNS receptors))
                            (PP (IN on)
                              (NP (DT the) (NN target) (NN cell) (NN surface)))))))))))))))
    (. .)))

(ROOT
  (S
    (S
      (NP (DT This) (JJ small) (NN latent) (NN complex))
      (VP (MD can)
        (VP (VB be)
          (VP (VBN associated)
            (PP (IN with)
              (NP (DT the) (NN latent) (NN TGF-β1-binding) (NN protein)))))))
    (, ,)
    (S
      (S
        (VP (VBG forming)
          (NP (DT a) (JJ large) (NN latent) (NN complex))))
      (VP (VBD thought)
        (S
          (VP (TO to)
            (VP (VB serve)
              (PP (IN as)
                (NP
                  (NP (DT a) (NN tether))
                  (PP (IN for)
                    (NP (VBG binding) (NNS proteins))))))))))
    (CC and)
    (S
      (NP (NN matrix) (NNS molecules))
      (VP (VBZ -LSB-)
        (NP (CD 31) (NNS -RSB-))))
    (. .)))

(ROOT
  (S
    (PP (IN In)
      (NP (DT this) (NN configuration)))
    (, ,)
    (NP (NNP TGF-β))
    (VP
      (VP (VBZ is) (RB not)
        (ADJP (JJ active)))
      (CC but)
      (VP (VBZ requires)
        (NP
          (NP (NN cleavage)
            (CC or)
            (NN dissociation))
          (PP (IN from)
            (NP (NNP LAP))))
        (S
          (VP (TO to)
            (VP (VB enable)
              (NP (PRP$ its) (NN interaction))
              (PP (IN with)
                (NP
                  (NP (PRP$ its) (JJ cognate) (NN receptor) (NN complex))
                  (, ,)
                  (NP (NNP TβRII))
                  (CC and)
                  (NP (NNP TβRI) (NNP -LSB-) (CD 32) (NNP -RSB-)))))))))
    (. .)))

(ROOT
  (SINV
    (S
      (NP
        (NP (NNP Activation))
        (PP (IN of)
          (NP (NNP TGF-β))))
      (VP (MD can)
        (VP (VB occur)
          (PP (IN by)
            (NP
              (NP (DT any))
              (PP (IN of)
                (NP
                  (NP (DT a) (NN number))
                  (PP (IN of)
                    (NP
                      (NP (NNS mechanisms))
                      (PP (VBG including)
                        (NP
                          (NP
                            (ADJP (JJ cleavage)
                              (PP (IN with)
                                (NP (NN plasmin))))
                            (NNS -LSB-))
                          (ADJP (CD 33) (JJ -RSB-))
                          (, ,)
                          (VP (VBN interaction)
                            (PP (IN with)
                              (NP (CD αvβ6)))))))))))))))
    (VP (VBZ -LSB-)
      (NP
        (NP
          (QP (CD 34) (CD -RSB-)))
        (, ,)
        (CC or)
        (NP
          (NP (IN through) (DT an) (JJ ill-defined) (NN interaction))
          (PP (IN of)
            (NP (NNP LAP)))))
      (PP (IN with)
        (NP (NN thrombospondin))))
    (NP
      (NP (PRP I))
      (PRN (-LRB- -LRB-)
        (NP (NNP TSP-I))
        (-RRB- -RRB-))
      (, ,)
      (NP
        (NP (DT a)
          (ADJP (JJ ligand)
            (PP (IN for)
              (NP (DT the) (NNP CD36) (NN receptor))))
          (NN -LSB-))
        (NP (CD 35) (NNS -RSB-))))
    (. .)))

(ROOT
  (S
    (S
      (VP
        (VP (VBG Adding)
          (ADJP (JJ credence)
            (PP (TO to)
              (NP
                (NP (DT a) (NN role))
                (PP (IN for)
                  (NP
                    (NP (NN TSP-1))
                    (, ,)
                    (NP
                      (NP (DT the) (NN TSP-1-null) (NNS mice) (NN exhibit))
                      (NP (JJ persistent) (NN inflammation))
                      (, ,)
                      (ADVP (RB particularly)
                        (PP (IN in)
                          (NP (DT the) (NN pancreas)
                            (CC and)
                            (NN lung)))))
                    (, ,)))))))
        (CC and)
        (VP (NN display)
          (NP (DT a) (NN phenotype))
          (PP (IN with)
            (NP (NNS similarities)))
          (PP (TO to)
            (NP (JJ TGF-β-null) (NNS mice))))))
    (VP (VBP -LSB-)
      (NP (CD 36,37) (NNS -RSB-))
      (, ,)
      (SBAR (IN although)
        (S
          (VP (TO to)
            (VP
              (NP (DT a) (JJR lesser) (NN extent))
              (PP (IN because)
                (NP
                  (NP (JJ alternative) (NNS mechanisms))
                  (PP (IN of)
                    (NP (JJ TGF-β) (NN activation) (NNS compensate))))))))))
    (. .)))

(ROOT
  (S
    (ADVP (RB Nonetheless))
    (, ,)
    (S
      (NP (NNP TSP-1))
      (VP (VBZ is)
        (NP
          (NP (DT a) (JJ major) (NN activator))
          (PP (IN of)
            (NP
              (NP (NNS TGF-β1))
              (PP (IN in)
                (NP (JJ vivo) (NNP -LSB-) (CD 36) (NNS -RSB-))))))))
    (, ,)
    (CC and)
    (S
      (NP (DT a) (NNP TSP))
      (VP (VBP peptide)
        (SBAR (IN that)
          (S
            (NP (NNP activates) (NNP TGF-β))
            (VP (VBZ reverses)
              (NP (DT the) (NN TSP-1-null) (NN phenotype))
              (PP (IN by)
                (S
                  (VP (VBG dampening)
                    (NP (DT the) (NN tissue) (NN inflammation))))))))))
    (. .)))

(ROOT
  (S
    (PP (IN In)
      (NP (DT a) (NN feedback) (NN loop)))
    (, ,)
    (S
      (NP (NNP TGF-β))
      (VP (VBZ augments)
        (NP (NNP TSP) (NN secretion))
        (PP (IN by)
          (NP (JJ dendritic) (NNS cells)
            (CC and)
            (NNS macrophages)))))
    (, ,)
    (CC and)
    (S
      (NP (NNP TGF-β-treated) (NNP APCs))
      (VP (VBP facilitate)
        (SBAR
          (S
            (NP
              (NP (DT the) (NN generation))
              (PP (IN of)
                (NP (JJ regulatory) (NNP T) (NNS cells))))
            (VP (VBD -LSB-)
              (NP (CD 38) (NNS -RSB-))
              (, ,)
              (S
                (VP (VBG creating)
                  (S
                    (NP (DT an) (NN environment))
                    (ADJP (JJ favorable)
                      (PP (IN for)
                        (NP
                          (NP (DT the) (NN induction))
                          (PP (IN of)
                            (NP (NN suppression) (NN and/or) (NN tolerance))))))
                    (S
                      (VP (TO to)
                        (VP (VB ensure)
                          (NP
                            (NP (DT the) (NN blunting))
                            (PP (IN of)
                              (NP (DT any) (JJ inflammatory) (NN reaction)))))))))))))))
    (. .)))

(ROOT
  (S
    (S
      (ADVP (RB Often))
      (ADJP (RB seeming) (JJ paradoxical)))
    (, ,)
    (NP (NNP activated) (NNP TGF-β))
    (VP (VBZ has)
      (NP
        (NP
          (ADJP (DT both) (JJ stimulatory)
            (CC and)
            (JJ inhibitory))
          (NNS influences))
        (PP (IN on)
          (NP (NNP T) (NN cell) (NN function) (NNP -LSB-) (NNP 6,8) (NNP -RSB-)))))
    (. .)))

(ROOT
  (S
    (NP (DT These)
      (ADJP (RB apparently) (JJ disparate))
      (NNS effects))
    (VP (VBP are)
      (ADJP (JJ dependent)
        (PP (IN on)
          (NP
            (NP (NN context))
            (, ,)
            (PP (VBG including)
              (NP
                (NP
                  (NP (NN state))
                  (PP (IN of)
                    (NP (NN differentiation))))
                (, ,)
                (NP
                  (NP (NN presence))
                  (PP (IN of)
                    (NP (JJ other) (NN growth) (NNS factors))))
                (CC or)
                (NP
                  (NP (NNS cytokines))
                  (, ,)
                  (NP (NN matrix) (NNS molecules))
                  (, ,)
                  (NP (JJ additional) (JJ proximal) (NN cell) (NNS populations))
                  (, ,)
                  (CC and)
                  (NP (JJ membrane) (NN receptor) (NNS levels)))))))))
    (. .)))

(ROOT
  (S
    (PP (IN Beyond)
      (NP
        (NP (PRP$ its) (NN involvement))
        (PP (IN in)
          (NP (JJ contact-dependent) (NN suppression)))))
    (, ,)
    (NP (JJ soluble) (NNS TGF-β))
    (VP (MD can)
      (ADVP (RB directly))
      (VP
        (VP (VB inhibit)
          (NP (NNP T) (NN cell) (NN proliferation)))
        (, ,)
        (VP (VB suppress)
          (NP (JJ macrophage) (NN activation)))
        (CC and)
        (VP (VB modulate)
          (NP
            (NP (JJ dendritic) (NN cell) (NN function))
            (PP (IN in)
              (NP (PRP$ its) (NN role))))
          (PP (IN as)
            (NP (DT an) (JJ immunoregulatory) (NN cytokine))))))
    (. .)))

(ROOT
  (S
    (NP
      (NP (NNP Deletion))
      (PP (IN of)
        (NP (DT this) (NN cytokine))))
    (VP (VBZ is)
      (VP (VBN associated)
        (PP (IN with)
          (NP
            (NP (JJ lethal) (JJ immune) (NN dysregulation))
            (CC and)
            (NP (JJ multi-organ) (JJ inflammatory) (NN disease) (NNP -LSB-) (CD 39,40) (NNP -RSB-))))))
    (. .)))

(ROOT
  (S
    (PP (IN In)
      (S
        (VP (VBG mediating)
          (NP (PRP$ its) (JJ suppressive) (NNS effects)))))
    (, ,)
    (NP (NNP TGF-β))
    (VP (VBZ signals)
      (PP (IN through)
        (NP
          (NP (DT the) (NN type) (NN I)
            (CC and)
            (NN type) (NNP II) (NNP TGF-β) (NN serine))
          (: --)
          (NP
            (NP (JJ threonine) (NN kinase) (NNS receptors))
            (, ,)
            (NP (NNP TβRI))
            (CC and)
            (NP (NNP TβRII))))))
    (. .)))

(ROOT
  (S
    (NP
      (NP (NNP Interaction))
      (PP (IN of)
        (NP
          (NP (DT the) (NN TGF-β))
          (VP (VBN ligand)
            (PP (IN with)
              (NP
                (NP (DT these) (NNS receptors))
                (PP (IN on)
                  (NP (NN target) (NNS cells)))))))))
    (VP (VBZ engages)
      (SBAR
        (S
          (NP (DT a) (JJ signaling) (NN cascade))
          (VP (VBD precipitated)
            (PP (IN by)
              (NP
                (NP (DT the) (NN phosphorylation))
                (PP (IN of)
                  (NP
                    (NP (JJ cytosolic) (NNS proteins))
                    (VP (VBN identified)
                      (PP (IN as)
                        (NP (NNP Smads) (NNP -LSB-) (CD 41,42) (NNS -RSB-))))))))))))
    (. .)))

(ROOT
  (S
    (SBAR
      (WHADVP (WRB When))
      (S
        (NP (NNP CD4) (NNP +) (NNP CD25) (NNP +) (NNP Treg))
        (VP (VBP are)
          (VP (VBN co-cultured)
            (PP (IN with)
              (NP
                (NP (NNP TCR-activated) (NNP CD4) (NNP +) (NNP CD25))
                (: -)
                (NP (NN responder) (NN T) (NNS cells))))))))
    (, ,)
    (NP (EX there))
    (VP (VBZ is)
      (NP
        (NP (DT a) (JJ rapid) (NN engagement))
        (PP (IN of)
          (NP
            (NP (DT this) (NN intracellular))
            (VP (VBG signaling)
              (ADVP (RB pathway)))))
        (SBAR
          (WHNP (WDT that))
          (S
            (VP (VBZ is)
              (ADJP (JJ consistent)
                (PP (IN with)
                  (NP (NNP TGF-β))))
              (SBAR (IN as)
                (S
                  (NP
                    (NP (DT the) (NN link))
                    (PP (IN between)
                      (NP
                        (NP (DT these) (CD two) (NNS cells))
                        (CC and)
                        (NP (DT the) (JJ impending) (JJ functional) (NN inhibition)))))
                  (VP (VBD manifested)
                    (PP (IN in)
                      (NP (DT the) (NN responder) (NN cell) (NN population)))
                    (S
                      (VP (VBG -LSB-)
                        (NP (CD 6,12,15) (NNS -RSB-))))))))))))
    (. .)))

(ROOT
  (S
    (PP (IN In)
      (NP (DT this) (NN regard)))
    (, ,)
    (NP
      (NP (NN phosphorylation))
      (PP (IN of)
        (NP (NNP Smads)))
      (, ,)
      (VP
        (ADVP (RB initially))
        (VBN detected)
        (PP (IN with)
          (NP
            (NP (NNS antibodies))
            (SBAR
              (WHNP (WDT that))
              (S
                (VP (VBP recognize)
                  (S
                    (NP (DT both) (NNS Smad2)
                      (CC and)
                      (NNS Smad3))
                    (VP
                      (VP (VBG -LSB-)
                        (NP
                          (NP
                            (QP (CD 6) (CD -RSB-)))
                          (PRN (-LRB- -LRB-)
                            (NP
                              (NP (NNP W) (NNP Chen))
                              (, ,)
                              (NP (JJ unpublished) (NNS data)))
                            (-RRB- -RRB-))))
                      (, ,)
                      (CC and)
                      (VP
                        (ADVP
                          (ADVP (RBR more) (RB recently))
                          (PP (IN with)
                            (NP (NN Smad2-specific) (NNS antibodies))))
                        (VBG -LSB-)
                        (NP (CD 15) (NNS -RSB-)))))))))))
      (, ,))
    (VP (VBD occurred)
      (PP (IN within)
        (NP (NNS minutes)))
      (PP (IN after)
        (NP
          (NP (NN exposure))
          (PP (IN of)
            (NP (JJ responder) (NNP T) (NNS cells)))))
      (PP (TO to)
        (NP (NNP Treg))))
    (. .)))

(ROOT
  (S
    (NP (NNS Smad2)
      (CC and)
      (NNS Smad3))
    (VP (VBP serve)
      (PP (IN as)
        (NP (JJ receptor-activated) (NNP Smad) (NNP signaling) (NNS intermediates)))
      (, ,)
      (SBAR (IN whereas)
        (S
          (NP (NNS Smad4))
          (VP (VBZ is)
            (NP
              (NP (DT a) (JJ common) (NN Smad))
              (SBAR
                (WHNP
                  (NP (WDT that) (NNS complexes))
                  (PP (IN with)
                    (NP (NNS Smad2/3))))
                (S
                  (VP (TO to)
                    (VP (VB enable)
                      (NP (NN translocation))
                      (PP (TO to)
                        (NP (DT the) (NN nucleus))))))))))))
    (. .)))

(ROOT
  (S
    (SBAR (IN Once)
      (S
        (PP (IN within)
          (NP (DT the) (NN nucleus)))
        (, ,)
        (NP (DT the) (NNP Smad) (NN complex))
        (VP (MD may)
          (VP (VB interact)
            (PP
              (PP (IN with)
                (NP (JJ specific) (NN DNA) (NNS sequences)))
              (CC and)
              (PP (IN with)
                (NP
                  (NP (JJ multiple) (JJ specific) (NN transcription) (NNS factors))
                  (, ,)
                  (CONJP (IN in) (NN addition) (TO to))
                  (NP (JJ transcriptional) (NNS coactivators))))
              (NP (NN and/or) (NNS co-repressors)))))))
    (, ,)
    (S
      (VP (VBG culminating)
        (PP (IN in)
          (NP
            (NP (DT the) (NN transcription))
            (PP (IN of)
              (NP (NN target) (NNS genes)))))))
    (CC and)
    (S
      (NP
        (NP (DT the) (NN transduction))
        (PP (IN of)
          (NP
            (NP (DT a) (NN variety))
            (PP (IN of)
              (NP
                (NP (NNS signals))
                (ADJP (JJ dependent)
                  (PP (IN on)
                    (NP (DT the) (NN target) (NN cell)))))))))
      (VP (VBZ -LSB-)
        (NP (CD 41) (NNS -RSB-))))
    (. .)))

(ROOT
  (S
    (NP (NNP Smad2/3))
    (VP (VBP are)
      (VP (VBN anchored)
        (PP (TO to)
          (NP (DT the) (NN plasma) (NN membrane)))
        (PP (IN through)
          (NP
            (NP (DT the) (NNP Smad) (NNP anchor))
            (PP (IN for)
              (NP
                (NP
                  (NP (NN receptor) (NN activation))
                  (PRN (-LRB- -LRB-)
                    (NP (NNP SARA))
                    (-RRB- -RRB-)))
                (, ,)
                (SBAR
                  (WHNP (WDT which))
                  (S
                    (ADVP (RB probably))
                    (VP (VBZ increases)
                      (NP
                        (NP (DT the) (NN efficiency))
                        (PP (IN of)
                          (NP (NN activation))))
                      (PP (IN by)
                        (NP
                          (NP (DT the) (JJ TGF-β-receptor) (NNS complexes))
                          (VP (VBG -LSB-)
                            (NP (CD 43) (NNS -RSB-))))))))))))))
    (. .)))

(ROOT
  (S
    (NP
      (NP (NNP Smad2))
      (, ,)
      (CONJP (RB rather) (IN than))
      (NP (NNS Smad3))
      (, ,))
    (VP (MD may)
      (VP (VB be)
        (NP
          (NP (DT the) (JJ critical) (NN connector))
          (PP (IN in)
            (NP
              (NP (DT the) (NN intracellular))
              (VP (VBG signaling)
                (ADVP (RB pathway))
                (S
                  (VP (VBN engaged)
                    (PP (IN in)
                      (NP (DT the) (NN responder) (NNS cells)))
                    (PP (IN by)
                      (NP (NNP Treg) (JJ surface-bound) (NN TGF-β)))
                    (, ,)
                    (SBAR (IN because)
                      (S
                        (NP
                          (NP (NNS mice) (NN deficient))
                          (PP (IN in)
                            (NP (NNS Smad3))))
                        (VP (NN respond)
                          (PP
                            (PP (TO to)
                              (NP (NNP Treg) (NNP suppression)))
                            (CC and)
                            (PP
                              (ADVP (RB also))
                              (TO to)
                              (NP
                                (NP (NNS exogenous))
                                (VP (VBG TGF-β)
                                  (NP
                                    (NP
                                      (QP (CD -LSB-) (CD 6))
                                      (NNS -RSB-))
                                    (PRN (-LRB- -LRB-)
                                      (NP
                                        (NP (NNP W) (NNP Chen))
                                        (, ,)
                                        (NP (JJ unpublished) (NNS data)))
                                      (-RRB- -RRB-))))))))))))))))))
    (. .)))

(ROOT
  (S
    (PP (IN In)
      (NP
        (NP (NN addition))
        (PP (TO to)
          (NP
            (NP (DT that))
            (VP (VBN mediated)
              (PP (IN by)
                (NP (NNS Smad2))))))))
    (, ,)
    (NP (NNP TGF-β) (NNP signaling))
    (VP (VBZ is)
      (VP (VBN regulated)
        (PP (IN by)
          (NP
            (NP (JJ complex) (NNS mechanisms))
            (PP (IN in)
              (NP (DT the) (NN cytoplasm)
                (CC and)
                (NN nucleus)))))))
    (. .)))

(ROOT
  (S
    (PP (IN Beyond)
      (NP (JJ engaging) (NNP Smad) (NN activity)))
    (, ,)
    (NP (NNP TGF-β))
    (VP (VBZ triggers)
      (SBAR
        (S
          (NP
            (NP (DT the) (JJ extracellular) (JJ signal-related) (NN kinase))
            (CC and)
            (NP (JJ p38) (JJ mitogen-activated) (NN kinase) (NNS pathways)))
          (VP (VBD -LSB-)
            (NP (CD 44) (NNS -RSB-))
            (S
              (VP (TO to)
                (VP (VB link)
                  (NP
                    (NP (JJ additional) (JJ signaling) (NNS cascades))
                    (VP (VBN involved)
                      (PP (IN in)
                        (S
                          (VP (VBG modulating)
                            (NP (NN cell) (NN function))))))))))))))
    (. .)))

(ROOT
  (S
    (NP
      (NP (NNS Perturbations))
      (PP (IN in)
        (NP (DT this) (JJ immunoregulatory) (NN circuit))))
    (VP (MD can)
      (VP (VB occur)
        (PP (IN through)
          (NP
            (NP (NN dysregulation))
            (PP (IN of)
              (NP (DT the) (JJ inhibitory) (NN Smad)))))
        (, ,)
        (NP
          (NP (NNS Smad7))
          (, ,)
          (SBAR
            (WHNP (WDT which))
            (S
              (ADVP (RB typically))
              (VP (VBZ represses)
                (NP
                  (NP (NNP TGF-β))
                  (VP (VBG signaling)
                    (PP (IN by)
                      (S
                        (VP (VBG interacting)
                          (PP (IN with)
                            (NP (VBN activated) (NN TGF-β) (NNS receptors))))))))))))
        (S
          (VP (TO to)
            (VP (VB prevent)
              (NP
                (NP (DT the) (NN activation))
                (PP (IN of)
                  (NP (JJ Smad2/3) (NN and/or))))
              (PP (IN by)
                (S
                  (VP (VBG interfering)
                    (PP (IN with)
                      (S
                        (NP
                          (NP (JJ complex) (NN formation))
                          (PP (IN between)
                            (NP (NNS Smad2/3)
                              (CC and)
                              (NNS Smad4))))
                        (VP (VBG -LSB-)
                          (NP (CD 45) (NNS -RSB-)))))))))))))
    (. .)))

(ROOT
  (SINV
    (VP (VBG Facilitating)
      (NP (DT the) (JJ inhibitory) (NNP Smad) (NNS signals)))
    (VP (VBP are)
      (NP (DT the) (NNP Smad) (NN ubiquitin)))
    (NP
      (NP (JJ regulatory) (NNS factors))
      (PRN (-LRB- -LRB-)
        (NP (NNP Smurfs))
        (-RRB- -RRB-))
      (, ,)
      (NP
        (NP (JJ E3) (NN ubiquitin) (NNS ligases))
        (, ,)
        (NP
          (ADJP (JJ capable)
            (PP (IN of)
              (S
                (VP (VBG inducing)
                  (NP
                    (NP (NN polyubiquitination)
                      (CC and)
                      (NN degradation))
                    (PP (IN of)
                      (NP (NNP TβRI) (NNP -LSB-) (CD 46,47))))))))
          (NNS -RSB-))))
    (. .)))

(ROOT
  (S
    (NP (NNP Smad7))
    (VP (VBZ is)
      (ADJP (JJ inducible)
        (PP (IN by)
          (S
            (VP (VBG TGF-β)
              (NP (PRP itself))
              (PP
                (PP (IN as)
                  (NP
                    (NP (NN part))
                    (PP (IN of)
                      (NP (DT a) (NN feedback) (NN loop)))))
                (, ,)
                (CONJP (RB as) (RB well) (IN as))
                (PP (IN by)
                  (S
                    (NP (DT the) (NNP IFN-γ)
                      (CC and)
                      (NNP NF-κB) (NNS pathways))
                    (VP (VBG -LSB-)
                      (NP (CD 41) (NNS -RSB-)))))))))))
    (. .)))

(ROOT
  (S
    (ADVP (RB Moreover))
    (, ,)
    (NP
      (NP (DT the) (JJ transcriptional) (JJ co-repressors) (NN c-Ski))
      (CC and)
      (NP (NNP SnoN)))
    (PRN (, ,)
      (PP (IN by)
        (NP
          (NP (NNS means))
          (PP (IN of)
            (NP
              (NP (PRP$ their) (NNS interactions))
              (PP (IN with)
                (NP (NNS Smad2/3/4)))))))
      (, ,))
    (VP
      (VP (VBZ repress)
        (NP (JJ TGF-β-induced) (NN transcription)))
      (CC and)
      (VP (VBP are)
        (VP (VBN upregulated)
          (PP (IN by)
            (NP (NNP TGF-β)))
          (PP (IN as)
            (NP (DT another) (JJ negative) (NN feedback) (NN loop)))
          (S
            (VP (TO to)
              (VP (VB maintain)
                (NP
                  (NP (NN control))
                  (PP (IN of)
                    (NP
                      (NP (DT this)
                        (ADJP (RB incredibly) (JJ powerful))
                        (NN molecule))
                      (VP (VBG -LSB-)
                        (NP (CD 41) (NNS -RSB-))))))))))))
    (. .)))

(ROOT
  (S
    (NP
      (NP (NNP Dissection))
      (PP (IN of)
        (NP (DT these) (NNS circuits))))
    (VP (MD will)
      (ADVP (RB probably))
      (VP (VB reveal)
        (NP (NNS pathways))
        (PP (IN by)
          (SBAR
            (WHNP (WDT which))
            (S
              (NP (NN suppression))
              (VP (MD can)
                (VP (VB be)
                  (VP (VBN manipulated)
                    (S
                      (VP (TO to)
                        (VP (VB orchestrate)
                          (NP (NNS changes))
                          (PP (IN in)
                            (NP (JJ aberrant) (NN immunity))))))))))))))
    (. .)))

(ROOT
  (S
    (SBAR (IN Although)
      (S
        (NP
          (NP (DT the) (NN preponderance))
          (PP (IN of)
            (NP (NN evidence))))
        (VP (VBZ supports)
          (NP
            (NP (DT a) (JJ major) (NN role))
            (PP (IN for)
              (NP (NNP TGF-β))))
          (PP (IN in)
            (NP
              (NP (DT the) (NN mediation))
              (PP (IN of)
                (NP (NNP Treg) (JJ suppressive) (NN activity))))))))
    (, ,)
    (NP (EX there))
    (VP (VBP are)
      (ADJP (JJ likely)
        (S
          (VP (TO to)
            (VP (VB be)
              (NP
                (NP (JJ additional) (NNS factors))
                (SBAR
                  (S
                    (NP (NN and/or))
                    (VP (VBZ cofactors)
                      (SBAR
                        (SBAR
                          (WHNP (WDT that))
                          (S
                            (ADVP (RB secondarily))
                            (VP (VBP contribute)
                              (PP (TO to)
                                (NP (PRP$ their) (NN function))))))
                        (CC and)
                        (SBAR
                          (WHNP (WDT that))
                          (S
                            (VP (MD may)
                              (VP (VB become)
                                (ADJP (JJ prevalent)
                                  (PP (IN in)
                                    (NP
                                      (NP (DT the) (NN absence))
                                      (PP (IN of)
                                        (NP (JJ TGF-β) (NN and/or))))))
                                (SBAR (IN if)
                                  (S
                                    (NP (NNP TGF-β))
                                    (VP (VBZ is)
                                      (VP (VBN dysregulated)))))))))))))))))))
    (. .)))

(ROOT
  (S
    (NP
      (NP (DT The) (NN identification)
        (CC and)
        (NN intersection) (NNS points))
      (PP (IN of)
        (NP (JJ such) (NNS pathways))))
    (VP (VBP await)
      (NP (JJ further) (NN study)))
    (. .)))

(ROOT
  (SINV
    (PP (IN Among)
      (NP
        (NP (DT the) (NNS factors))
        (SBAR
          (WHNP (WDT that))
          (S
            (VP (VBP contribute)
              (PP (TO to)
                (NP
                  (NP (DT the) (NN regulation))
                  (PP (IN of)
                    (NP (NNP TGF-β))))))))))
    (VP
      (PP (IN in)
        (NP (NNP CD4) (NNP +) (NNP CD25) (NNP +) (NNP Treg)))
      (VBP are)
      (NP (NNP CD28) (, ,) (JJ cytotoxic) (NNP T)))
    (NP
      (NP (NN lymphocyte)
        (UCP
          (NP (JJ antigen-4) (, ,) (JJ glucocorticoid-induced) (NNP TNF) (NN receptor))
          (CC and)
          (VP (VBN forkhead/winged)))
        (NN helix))
      (CC or)
      (NP
        (NP (JJ forkhead) (NN box) (NN P3))
        (VP (VBN encoded)
          (PP (IN by)
            (NP (NNP Foxp3) (NNP -LSB-) (NNP 48-51) (NNP -RSB-))))))
    (. .)))

(ROOT
  (S
    (NP
      (NP (NNP Generation))
      (PP (IN of)
        (NP (NNP Treg))))
    (SBAR (IN Although)
      (S
        (NP (NNP Treg))
        (VP (VBD were)
          (ADVP (RB originally))
          (VP (VBN considered)
            (S
              (VP (TO to)
                (VP (VB derive)
                  (ADVP (RB only))
                  (PP (IN from)
                    (NP (JJ thymic) (NNS precursors))))))))))
    (VP (VBD -LSB-)
      (NP (CD 1) (NNS -RSB-))
      (, ,)
      (S
        (VP
          (VP (TO to)
            (VP (VB be)
              (VP (VBN exported)
                (PP (TO to)
                  (NP (DT the) (NN periphery))))))
          (, ,)
          (CC and)
          (VP (TO to)
            (VP (VB represent)
              (NP
                (NP
                  (NP
                    (QP (JJR less) (IN than) (CD 10))
                    (NN %))
                  (PP (IN of)
                    (NP (NNP CD4) (NNP +) (NNP T) (NNS cells)))
                  (ADJP (JJ -LSB-)
                    (NP (CD 52) (NNS -RSB-)))
                  (, ,)
                  (VP
                    (ADVP (RB thereby))
                    (VBG limiting)
                    (NP (PRP$ their) (NN potential))
                    (PP (IN for)
                      (NP
                        (NP (NN manipulation))
                        (PP (IN for)
                          (NP (JJ therapeutic) (NNS considerations))))))
                  (, ,)
                  (NP
                    (NP (JJ important) (JJ new) (NN evidence) (NNS documents))
                    (SBAR (IN that)
                      (S
                        (NP (NNP Treg))
                        (VP (MD can)
                          (VP (VB be)
                            (VP (VBN expanded)
                              (NP (JJ and/or)
                                (ADJP (FW induced) (FW de))
                                (NN novo))
                              (PP (IN from)
                                (NP (NNP CD4) (NNP +) (NNP CD25))))))))))
                (: -)
                (NP
                  (NP (NNP precursor) (NNP T))
                  (NP (NNS cells)))))))))
    (. .)))

(ROOT
  (SBARQ
    (WHADVP (WRB How))
    (, ,)
    (WHADVP (WRB where))
    (PRN (, ,)
      (S
        (VP (VB and)
          (SBAR (IN if)
            (S
              (NP
                (NP (DT the) (NN size)
                  (CC and)
                  (NN function))
                (PP (IN of)
                  (NP (DT this) (NN population))))
              (VP (MD can)
                (VP (VB be)
                  (VP
                    (ADVP (RB intentionally))
                    (VBN controlled)))))))))
    (SQ (VBZ is)
      (PP (IN of)
        (NP (DT the) (JJ utmost) (NN importance))))
    (. .)))

(ROOT
  (S
    (S
      (NP
        (NP (DT The) (JJ thymic) (NN derivation))
        (PP (IN of)
          (NP (NNP Treg))))
      (VP (VBZ is)
        (ADJP
          (ADJP (RB genetically) (RB as))
          (CONJP (RB well) (IN as))
          (ADJP (RB developmentally) (VBN regulated)))))
    (, ,)
    (CC but)
    (S
      (NP (PRP it))
      (VP (VBZ seems)
        (S
          (VP (TO to)
            (VP (VB be)
              (ADJP
                (ADJP (JJ constitutive))
                (CC and)
                (ADJP (RB relatively) (JJ stable))))))))
    (. .)))

(ROOT
  (S
    (NP
      (NP (NNP Recruitment))
      (PP (TO to)
        (NP
          (NP (DT a) (NN site))
          (PP (IN of)
            (NP (JJ autoimmune) (NN reactivity))))))
    (VP (MD may)
      (VP
        (VP (VB increase)
          (NP (PRP$ their) (NNS numbers))
          (ADVP (RB locally)))
        (, ,)
        (CC but)
        (VP
          (PP (IN in)
            (NP (DT a) (JJ limited) (NN fashion))))))
    (. .)))

(ROOT
  (S
    (NP (DT The) (NN ability)
      (S
        (VP (TO to)
          (VP (VB coerce)
            (NP
              (NP (NN expansion))
              (PP (IN of)
                (NP (NNP functional) (NNP Treg))))))))
    (VP (VBZ opens)
      (PRT (RP up))
      (NP
        (NP (NNS possibilities))
        (PP (IN for)
          (NP
            (NP (DT the) (NN manipulation))
            (PP (IN of)
              (NP (NN inflammation)
                (CC and)
                (NN immunity)))))))
    (. .)))

(ROOT
  (S
    (NP (NNP CD4) (NNP +) (NNP CD25) (NNP +) (NNP Treg))
    (VP (VBP undergo)
      (NP (NN proliferation))
      (PP (IN with)
        (NP
          (NP (NNP TCR) (NNP stimulation))
          (PP (IN in)
            (NP
              (NP (DT the) (NN presence))
              (PP (IN of)
                (NP
                  (NP (JJ high) (NNS doses))
                  (PP (IN of)
                    (NP
                      (NP
                        (NP (JJ exogenous) (NN IL-2))
                        (PRN (-LRB- -LRB-)
                          (NP
                            (QP (JJR more) (IN than) (CD 100) (CD U/ml)))
                          (-RRB- -RRB-)))
                      (PP (IN in)
                        (NP
                          (QP ($ vitro) (CD -LSB-) (CD 10))
                          (NNS -RSB-))))))))))))
    (. .)))

(ROOT
  (S
    (ADVP (RB Importantly))
    (, ,)
    (NP (DT these))
    (VP (VBD expanded)
      (SBAR
        (S
          (NP (NNP CD4) (NNP +) (NNP CD25))
          (VP (VBZ +)
            (S
              (NP (JJ regulatory) (NNP T) (NNS cells))
              (VP
                (VP (VB preserve)
                  (NP (PRP$ their) (JJ anergic) (NNS features)))
                (CC and)
                (VP (VB immunosuppressive)
                  (NP (NN ability))
                  (SBAR (IN once)
                    (S
                      (NP (NNP IL-2))
                      (VP (VBZ is)
                        (VP (VBN removed))))))))))))
    (. .)))

(ROOT
  (S
    (NP
      (NP (DT This) (JJ unique) (NN aspect))
      (PP (IN of)
        (NP (NNP CD4) (NNP +) (NNP CD25) (NNP +) (NNP Treg))))
    (VP (VBZ has)
      (NP
        (NP (JJ definite) (JJ potential) (NN application))
        (PP (IN in)
          (S
            (VP (VBG designing)
              (NP (JJ future) (JJ clinical) (NN therapy))
              (PP (IN for)
                (NP (JJ autoimmune) (NNS diseases) (, ,) (NN inflammation)
                  (CC and)
                  (NN transplantation))))))))
    (. .)))

(ROOT
  (S
    (ADVP (RB Nonetheless))
    (, ,)
    (NP
      (NP (DT the) (NN insufficiency))
      (PP (IN of)
        (ADVP (RB naturally))))
    (VP (VBD derived)
      (SBAR
        (S
          (NP
            (NP (NNP CD4) (NNP +) (NNP CD25) (NNP +) (NNP Treg))
            (PP (IN in)
              (NP (NN autoimmunity)
                (CC and)
                (JJ other) (JJ immune) (NNS diseases))))
          (VP (VBZ has)
            (VP (VBN driven)
              (NP (DT the) (NN search))
              (PP (IN for)
                (NP (NNS approaches)))
              (S
                (VP (TO to)
                  (VP (VB convert)
                    (NP
                      (ADJP (JJ normal) (JJ naive))
                      (ADJP
                        (NP (CD CD4) (NNS +))
                        (JJ CD25-T))
                      (NNS cells))
                    (PP (IN into)
                      (NP (NNP CD4) (NNP +) (NNP CD25) (NNP +) (JJ regulatory) (NN T) (NNS cells)))))))))))
    (. .)))

(ROOT
  (S
    (NP
      (NP (DT The) (NN generation))
      (PP (IN of)
        (NP (NN functionally))))
    (VP (VBD uncompromised)
      (SBAR
        (S
          (NP (NNP CD4) (NNP +) (NNP CD25) (NNP +) (NNP Treg))
          (VP (VBZ involves)
            (NP
              (NP
                (NP (DT the) (JJ unique) (NN induction))
                (PP (IN of)
                  (NP
                    (NP
                      (NP (JJ forkhead/winged) (NN helix) (NN transcription) (NN factor) (NNS Foxp3))
                      (PRN (-LRB- -LRB-)
                        (NP (NNP Scurfin))
                        (-RRB- -RRB-)))
                    (PP (IN in)
                      (NP (NNP Foxp3-negative) (NNP CD4) (NNP +) (NNP CD25))))))
              (: -)
              (NP (NNS precursors)))))))
    (. .)))

(ROOT
  (S
    (S
      (NP (NNP Foxp3))
      (VP (VBZ is)
        (ADJP (RB highly) (JJ conserved))))
    (, ,)
    (CC and)
    (S
      (PP (IN in)
        (NP (DT both) (NNS mice)
          (CC and)
          (NNS humans)))
      (NP
        (ADJP (RB genetically) (JJ defective))
        (NNS Foxp3))
      (VP (VBZ is)
        (VP (VBN associated)
          (PP (IN with)
            (NP (JJ autoimmune)
              (CC and)
              (JJ inflammatory) (NN disease)))
          (S
            (VP (VBG -LSB-)
              (NP (CD 48,53-57) (NNS -RSB-)))))))
    (. .)))

(ROOT
  (S
    (PP (IN In)
      (NP (JJ Foxp3) (JJ null) (NNS mice)))
    (, ,)
    (NP
      (NP (DT the) (NN deficiency))
      (PP (IN of)
        (NP (NNP CD4) (NNP +) (NNP CD25) (NNP +) (NNP Treg))))
    (VP (VBZ results)
      (PP (IN in)
        (NP
          (NP (DT a) (JJ lethal) (JJ autoimmune) (NN syndrome))
          (VP (VBG -LSB-)
            (NP (CD 53,55,57) (NNS -RSB-))))))
    (. .)))

(ROOT
  (S
    (PP (IN In)
      (ADJP (NN vitro)))
    (, ,)
    (NP
      (NP (NN gene) (NN transfer))
      (PP (IN of)
        (NP (NNS Foxp3))))
    (VP (VBZ converts)
      (NP
        (NP (NNP naive) (NNP CD4) (NNP +) (NNP CD25))
        (: -)
        (NP
          (NP (NNP T) (NNS cells))
          (PP (IN into)
            (NP
              (ADJP (JJ phenotypic)
                (CC and)
                (JJ functional))
              (NNP Treg) (NNP -LSB-) (CD 48,53,55,56) (NNS -RSB-)))
          (, ,)
          (SBAR
            (WHNP (WDT which))
            (S
              (VP (VBZ is)
                (ADJP (JJ consistent)
                  (PP (IN with)
                    (NP (DT the) (NN ability))))
                (S
                  (VP (TO to)
                    (VP (VB rescue)
                      (NP (NN Foxp3-null) (NNS mice))
                      (PP (IN with)
                        (NP
                          (NP (JJ adoptive) (NN transfer))
                          (PP (IN of)
                            (NP (NNP Treg) (NNP -LSB-) (CD 55) (NNS -RSB-))))))))))))))
    (. .)))

(ROOT
  (S
    (NP (DT These) (NNS data))
    (VP (VBP support)
      (NP
        (NP (DT the)
          (ADJP (JJ pivotal)
            (CC and)
            (JJ nonredundant))
          (NN role))
        (PP (IN of)
          (NP (DT this) (NN transcription) (NN factor))))
      (PP (IN in)
        (S
          (VP (VBG Treg)
            (NP (NN development)
              (CC and)
              (NN function))))))
    (. .)))

(ROOT
  (S
    (ADVP (RB Conversely))
    (, ,)
    (NP
      (NP (DT the) (NN overexpression))
      (PP (IN of)
        (NP (JJ Foxp3)
          (UCP
            (PP (IN in)
              (NP
                (NP (DT a) (JJ transgenic) (NN mouse) (NN model) (NNS results))
                (PP (IN in)
                  (NP
                    (NP (JJ enhanced) (NNS numbers))
                    (PP (IN of)
                      (NP
                        (NP (NNP CD4) (NNP +) (NNP CD25) (NNP +) (NNP Treg))
                        (CC and)
                        (PRN (, ,)
                          (ADVP (RB furthermore))
                          (, ,))
                        (NP (NNP Foxp3-expressing) (NNP CD4) (NNP +) (NNP CD25)))))))
              (: -))
            (, ,)
            (CONJP (RB as) (RB well) (IN as))
            (NP
              (NP
                (NP (NNP CD4-CD8) (NNP +))
                (, ,)
                (NP (NNP T) (NNS cells)))
              (PP (IN in)
                (NP (DT these) (JJ transgenic) (NNS mice) (NN constitutively) (NN exhibit) (NN suppressive)))))
          (NNS functions))))
    (VP (VBZ -LSB-)
      (NP (CD 57) (NNS -RSB-)))
    (. .)))

(ROOT
  (S
    (PP (IN Despite)
      (NP
        (NP
          (NP (DT the) (NN success))
          (PP (IN of)
            (NP
              (NP (DT the) (JJ artificial) (NN gene) (NN transfer))
              (PP (IN of)
                (NP
                  (NP (NNS Foxp3))
                  (PP (IN into)
                    (NP (NNP CD4) (NNP +) (NNP CD25))))))))
        (: -)
        (ADJP (JJ naive)
          (NP
            (NP (NNP T) (NNS cells))
            (S
              (VP (TO to)
                (VP (VB coerce)
                  (NP (PRP them))
                  (PP (IN into)
                    (NP (DT a) (NNP CD4) (NNP +) (NNP CD25) (NNP +) (JJ regulatory) (NN T) (NN cell) (NN phenotype))))))))))
    (, ,)
    (NP
      (NP (DT the) (NN existence))
      (PP (IN of)
        (NP
          (NP (DT a) (JJ physiologic) (NN inducer))
          (PP (IN of)
            (NP (NNS Foxp3))))))
    (VP (VBD was)
      (ADJP (JJ unknown)))
    (. .)))

(ROOT
  (S
    (S
      (NP
        (NP (DT The) (JJ recent) (NN elucidation))
        (PP (IN of)
          (NP (DT a) (JJ signaling) (NN pathway))))
      (VP (VBG leading)
        (PP (TO to)
          (NP
            (NP (DT the) (NN conversion))
            (PP (IN of)
              (NP (NNP CD4) (NNP +) (NNP CD25)))))))
    (: -)
    (S
      (NP
        (NP (NNS precursors))
        (PP (IN into)
          (NP (NNP Treg))))
      (VP (VBD revealed)
        (NP (DT a) (JJ pivotal) (NN role))
        (PP (IN for)
          (NP (NNP TGF-β) (NNP -LSB-) (CD 8,12,14) (NNS -RSB-)))))
    (. .)))

(ROOT
  (S
    (ADVP (RB Moreover))
    (, ,)
    (NP
      (NP (DT the) (JJ genetic) (NN deletion))
      (PP (IN of)
        (NP
          (NP (JJ Foxp3) (NNS results))
          (PP (IN in)
            (NP
              (NP (DT an) (VBG overlapping) (NN phenotype))
              (PP (IN with)
                (NP (DT the) (NN TGF-β1-null) (NNS mice))))))))
    (VP (VBD -LSB-)
      (NP (CD 40) (NNS -RSB-))
      (, ,)
      (S
        (VP (VBG implicating)
          (NP
            (NP (DT a) (NN connection) (NN and/or) (VBN shared) (NN mechanism))
            (PP (IN of)
              (NP (NN action)))))))
    (. .)))

(ROOT
  (S
    (NP
      (NP (DT The) (NN induction))
      (PP (IN of)
        (NP
          (NP (NN gene) (NN expression))
          (PP (IN of)
            (NP
              (NP (NNS Foxp3))
              (, ,)
              (NP
                (NP (DT a) (NN transcription) (NN factor))
                (ADJP (JJ unique)
                  (PP (TO to)
                    (NP (NNP Treg) (NNP -LSB-) (NNP 48,53-57) (NNP -RSB-))))))))))
    (VP (VBZ is) (, ,)
      (PP (IN in)
        (NP (NN fact)))
      (, ,)
      (ADJP (RB TGF-β) (JJ dependent))
      (S
        (VP (VBG -LSB-)
          (NP (CD 12) (NNS -RSB-)))))
    (. .)))

(ROOT
  (S
    (ADVP (RB However))
    (, ,)
    (NP (NNP TGF-β))
    (VP
      (VP (MD can) (RB not)
        (VP (VB act)
          (ADVP (RB independently))
          (PP (IN on)
            (NP (NN precursor) (NNS cells)))
          (S
            (VP (TO to)
              (VP (VB generate)
                (NP (NNP Treg)))))))
      (CC but)
      (VP (VBZ requires)
        (NP (NN co-stimulation))
        (PP (IN through)
          (NP (NNP TCR)
            (CC and)
            (NNP IL-2R) (NNP -LSB-) (CD 12,58) (NNS -RSB-)))))
    (. .)))

(ROOT
  (FRAG
    (NP (NNP Naive) (NNP splenic) (NNP CD4) (NNP +) (NNP CD25))
    (: -)
    (S
      (NP (NNP T) (NNS cells))
      (VP (VBD cultured)
        (PP (IN for)
          (NP
            (QP (CD 7) (TO to) (CD 9))
            (NNS days)))
        (PP (IN with)
          (NP
            (NP (NNP TCR) (NN stimulation)
              (CC and)
              (NN TGF-β))
            (PP (IN in)
              (NP
                (NP (DT the) (NN presence))
                (PP (IN of)
                  (NP
                    (NP (NNP APCs) (NNP emerge))
                    (PP (IN as)
                      (NP (NNP CD4) (NNP +) (NNP CD25) (NNP +) (NNP Treg)))))))))
        (PP (IN with)
          (NP (DT the) (NN ability)
            (S
              (VP (TO to)
                (VP (VB suppress)
                  (NP (NNP CD4) (NNP +) (NNP responder) (NNP T) (NN cell) (NN proliferation)))))))))
    (. .)))

(ROOT
  (S
    (NP (DT A) (JJ similar) (NN conversion) (NN pattern))
    (VP (VBZ occurs)
      (PP (IN in)
        (NP (NNP TCR) (JJ transgenic) (NNS mice)))
      (SBAR (IN if)
        (S
          (S
            (NP (DT the) (NNP CD4) (NNP +) (NNP CD25))
            (: -)
            (ADVP (RB naive))
            (NP (NNP T) (NNS cells))
            (VP (VBP are)
              (VP (VBN stimulated)
                (PP (IN with)
                  (NP (JJ specific) (NN antigen))))))
          (CC and)
          (S
            (NP
              (NP (NNP APCs))
              (PP (IN with)
                (NP (NNP TGF-β))))
            (VP (VBD added)
              (NP
                (QP (CD -LSB-) (CD 12))
                (NNS -RSB-)))))))
    (. .)))

(ROOT
  (S
    (NP
      (NP
        (NP (DT This) (NN engagement))
        (PP (IN of)
          (NP
            (NP (DT the) (NNP TCR))
            (CC and)
            (NP (JJ co-stimulator) (NNS molecules)))))
      (PRN (-LRB- -LRB-)
        (PP (JJ such) (IN as)
          (NP (NNP CD28)))
        (-RRB- -RRB-)))
    (VP (VBD -LSB-)
      (SBAR
        (S
          (NP
            (NP (CD 49,50,59,60) (NNS -RSB-))
            (PP (IN in)
              (NP
                (NP (NN concert))
                (PP (IN with)
                  (NP (NNP TβRII) (NN ligation))))))
          (VP (VBZ triggers)
            (S
              (VP (VBG signaling)
                (NP
                  (NP (NNS pathways))
                  (SBAR
                    (WHNP (WDT that))
                    (S
                      (VP (VBP culminate)
                        (PP (IN in)
                          (NP
                            (NP (JJ Foxp3) (NN transcription))
                            (, ,)
                            (SBAR
                              (WHNP (WDT which))
                              (S
                                (VP (VBZ is)
                                  (ADJP (JJ essential)
                                    (PP (TO to)
                                      (NP
                                        (NP (NN generation))
                                        (PP (IN of)
                                          (NP (NNP Treg)))))))))))))))))))))
    (. .)))

(ROOT
  (S
    (PP (IN In)
      (NP (DT this) (NN fashion)))
    (, ,)
    (NP (NNP TGF-β))
    (VP (VBZ is) (RB not)
      (VP
        (ADVP (RB only))
        (VBN expressed)
        (PP (IN by)
          (NP
            (NP (NNP Treg))
            (CONJP (CC but)
              (RB also))
            (NP
              (NP (NNS programs))
              (NP (PRP$ their) (NN development)
                (CC and)
                (NN function)))))))
    (. .)))

(ROOT
  (S
    (S
      (NP (NNP TGF-β-converted) (NNP Treg))
      (VP (VBP control)
        (NP
          (NP (JJ immune) (NNS responses))
          (PP (IN in)
            (NP (NN vivo))))
        (PP (IN On)
          (NP
            (NP (DT the) (NN basis))
            (PP (IN of)
              (NP
                (NP (DT this) (NN understanding))
                (PP (IN of)
                  (NP
                    (NP (DT the) (JJ novel) (NN mechanism) (VBG underlying) (NN conversion))
                    (PP (IN of)
                      (NP (NNP CD4) (NNP +) (NNP CD25)))))))))))
    (: -)
    (S
      (NP
        (NP (NNP T) (NNS cells))
        (PP (IN into)
          (NP
            (NP
              (ADJP (JJ phenotypic)
                (CC and)
                (JJ functional))
              (NNP CD4) (NNP +) (NNP CD25) (NNP +) (NNP Treg))
            (, ,)
            (NP
              (NP (DT the) (NN expansion))
              (PP (IN of)
                (NP
                  (NP (NNP Treg))
                  (PP (IN for)
                    (NP (JJ therapeutic) (NN consideration)))))))))
      (VP (VBZ becomes)
        (NP (DT an)
          (ADJP (JJ achievable))
          (NN goal))))
    (. .)))

(ROOT
  (S
    (S
      (VP (VBG Provided)
        (SBAR (IN that)
          (S
            (NP (DT the) (JJ regulatory) (NNS conditions))
            (VP (VBP are)
              (VP (VBN met)))))))
    (, ,)
    (NP (DT the) (JJ converted) (NNP CD4) (NNP +) (NNP CD25) (NNP +) (NNP Treg))
    (VP (VBP function)
      (PP (IN like)
        (NP
          (NP (JJ conventional) (NN Treg))
          (, ,)
          (ADVP (IN at) (JJS least))))
      (PP (IN in)
        (ADJP (NN vitro))))
    (. .)))

(ROOT
  (S
    (SBAR (IN Although)
      (S
        (NP (PRP it))
        (VP (VBZ has)
          (ADVP (RB previously))
          (VP (VBN been)
            (VP (VBN shown)
              (SBAR (IN that)
                (S
                  (NP
                    (ADJP (RB naturally) (JJ occurring))
                    (NNP CD4) (NNP +) (NNP CD25) (NNP +) (NNP Treg))
                  (VP (VBP are)
                    (NP
                      (NP (JJ potent) (NNS inhibitors))
                      (PP (IN of)
                        (NP (JJ innate/adaptive) (NN immunity) (NNP -LSB-) (NNP 61-63) (NNP -RSB-))))))))))))
    (, ,)
    (NP
      (NP (NN induction))
      (PP (IN of)
        (NP
          (NP
            (NP (DT a) (NN population))
            (PP (IN of)
              (NP (NNP Treg))))
          (CC and)
          (NP
            (NP (NN documentation))
            (PP (IN of)
              (NP (PRP$ their)))
            (PP (IN in)
              (NP (NN vivo) (NN potential)))))))
    (VP (VBD was)
      (NP (DT an) (JJ important) (JJ next) (NN step)))
    (. .)))

(ROOT
  (S
    (PP (IN In)
      (NP
        (NP (NN pursuit))
        (PP (IN of)
          (NP (DT this) (NN goal)))))
    (, ,)
    (NP (JJ recent) (NNS studies))
    (VP (VBD demonstrated)
      (PP (IN for)
        (NP (DT the) (JJ first) (NN time)))
      (SBAR (IN that)
        (S
          (NP
            (NP (DT the) (NN transfer))
            (PP (IN of)
              (PP (IN in)
                (NP (NNP vitro)))))
          (VP (VBD generated)
            (SBAR
              (S
                (NP
                  (NP (NNP Treg))
                  (PP (IN into)
                    (NP (NN disease) (NNS models))))
                (VP (VBZ does)
                  (PP (IN in)
                    (NP
                      (NP (NN fact) (NN ameliorate) (NNS pathogenesis))
                      (VP (VBG -LSB-)
                        (NP (CD 12) (NNS -RSB-))))))))))))
    (. .)))

(ROOT
  (S
    (ADVP (RB Initially))
    (, ,)
    (NP (PRP it))
    (VP (VBD was)
      (VP (VBN shown)
        (SBAR (IN that)
          (S
            (NP
              (NP (JJ adoptive) (NN transfer))
              (PP (IN of)
                (NP
                  (NP
                    (ADJP (IN in) (NN vitro))
                    (JJ TGF-β-converted) (NN Treg))
                  (ADVP (RB together)
                    (PP (IN with)
                      (NP (JJ ovalbumin-specific) (NNP TCR) (JJ transgenic) (NN T) (NNS cells)))))))
            (VP (VBD resulted)
              (PP (IN in)
                (NP
                  (NP (DT a) (JJ profound) (NN inhibition))
                  (PP (IN of)
                    (NP
                      (NP (JJ antigen-specific) (NN expansion))
                      (PP (IN of)
                        (NP
                          (ADJP (JJ naive)
                            (NP (CD CD4)))
                          (JJ +) (JJ transgenic) (NN T) (NNS cells)))))))
              (PP (IN in)
                (NP (NN vivo))))))))
    (. .)))

(ROOT
  (SINV
    (S
      (SBAR (IN Although)
        (S
          (NP
            (NP (DT the) (JJ TGF-β-converted) (NNP CD25) (NNP +) (NN suppressor) (NN population))
            (PRN (-LRB- -LRB-)
              (NP
                (NP (NNP DO11) (CD .10) (NNP TCR) (NNP transgenic))
                (, ,)
                (NP (NNP KJ1-26) (NNP +)))
              (-RRB- -RRB-)))
          (VP (VBN proliferated)
            (PP (IN in)
              (NP (NN vivo)))
            (PP (IN on)
              (NP (NN immunization)))
            (PP (IN with)
              (NP (NN ovalbumin) (NN peptide))))))
      (, ,)
      (NP (DT the) (NNP recovered) (NNP KJ1-26) (NNP +) (NNP CD4))
      (VP (VBZ +)
        (NP (NNP T) (NNS cells))
        (PP (IN from)
          (S
            (VP (VBG draining)
              (SBAR
                (S
                  (NP (NN lymph) (NNS nodes))
                  (VP (VBD remained)
                    (ADJP (JJ unresponsive)
                      (S
                        (VP (TO to)
                          (VP (VB re-challenge)
                            (PP (IN with)
                              (NP
                                (NP (NN ovalbumin) (NN peptide))
                                (PP (IN in)
                                  (NP (NNP vitro)))))))))))))))))
    (, ,)
    (VP
      (VP (VBD produced)
        (NP (DT no) (JJ antigen-specific) (NN IL-4)))
      (CC and)
      (VP (VBZ IFN-γ))
      (, ,)
      (CC and)
      (VP (VBD expressed)
        (NP
          (NP (JJ high) (NNS levels))
          (PP (IN of)
            (NP (NNP CD25) (NNP -LSB-))))))
    (NP
      (NP (CD 12) (NNS -RSB-))
      (, ,)
      (NP
        (NP (DT all)
          (ADJP (JJ consistent)
            (PP (IN with)
              (NP (JJ professional) (NNP CD4) (NNP +) (NNP CD25) (NNP +))))
          (JJ regulatory) (NN T) (NNS cells) (NN -LSB-))
        (NP (CD 64,65) (NNS -RSB-))))
    (. .)))

(ROOT
  (S
    (ADVP (RB Moreover))
    (, ,)
    (PP (IN in)
      (NP
        (NP (DT a) (JJ dramatic) (NN turnaround))
        (PP (IN of)
          (NP (JJ allergen-induced) (JJ asthmatic) (NN lung) (NN disease)))))
    (, ,)
    (NP
      (NP (NNP TGF-β-converted) (NNP /) (NNP induced) (NNP Treg))
      (, ,)
      (SBAR
        (WHADVP (WRB when))
        (S
          (VP (VBN transferred)
            (PP (TO to)
              (NP (DT an) (JJ asthmatic) (NN mouse))))))
      (, ,))
    (VP
      (VP (VBD suppressed)
        (NP (JJ allergen-induced) (NN inflammation)))
      (CC and)
      (VP (VBZ pathogenesis)
        (NP
          (QP (CD -LSB-) (CD 12))
          (NNS -RSB-))))
    (. .)))

(ROOT
  (SINV
    (S
      (PP (IN In)
        (NP (DT this) (NN model)))
      (, ,)
      (NP (NNS mice))
      (VP (VBP are)
        (VP
          (VP (VBN immunized)
            (PP (IN with)
              (NP (NN house) (NN dust) (NN mite))))
          (CC and)
          (VP
            (ADVP (RB then))
            (VBN challenged)
            (ADVP (RB intratracheally))
            (PP (IN with)
              (NP (NN house) (NN dust) (NN mite)))
            (S
              (VP (TO to)
                (VP (VB induce)
                  (ADJP (RB airway) (JJ hyperreactivity)))))))))
    (, ,)
    (VP (VBZ mucus))
    (NP
      (NP (NN accumulation))
      (, ,)
      (NP
        (NP (NN eosinophilia))
        (CC and)
        (NP (NN IgE) (NN production))))
    (. .)))

(ROOT
  (S
    (NP
      (NP (NN Delivery))
      (PP (IN of)
        (S
          (VP (VBG Treg)
            (PP (TO to)
              (NP
                (NP (DT these) (JJ asthmatic) (NNS mice))
                (PP (IN on)
                  (NP
                    (NP (NN day) (CD 0))
                    (CC and)
                    (NP (CD 14))))))))))
    (VP (VBD was)
      (ADJP (JJ able)
        (S
          (VP (TO to)
            (VP (VB prevent)
              (NP
                (NP
                  (NP (DT the) (JJ immunopathogenic) (NN response))
                  (PRN (-LRB- -LRB-)
                    (NP
                      (QP (CD Fig.) (CD 2)))
                    (-RRB- -RRB-)))
                (, ,)
                (VP (VBG confirming)
                  (NP
                    (NP (DT the)
                      (ADJP (JJ functional))
                      (NN prowess))
                    (PP (IN of)
                      (NP
                        (NP (DT these) (RB newly) (JJ converted) (NNS cells))
                        (PP (IN in)
                          (NP
                            (NP (DT the) (NN suppression))
                            (PP (IN of)
                              (NP
                                (NP
                                  (ADJP (JJ inflammatory)
                                    (CC and)
                                    (JJ immune))
                                  (NNS responses))
                                (PP (IN in)
                                  (NP (NN vivo)))))))))))))))))
    (. .)))

(ROOT
  (S
    (S
      (S
        (VP (VBG Treg)
          (PP (IN in)
            (NP (JJ autoimmune) (NNS diseases)))))
      (NP (JJ Human) (JJ systemic) (NNS lupus))
      (VP (VBZ erythematosus)
        (NP
          (PRN (-LRB- -LRB-)
            (NP (NNP SLE))
            (-RRB- -RRB-))
          (NNS patients))))
    (CC and)
    (S
      (NP
        (NP (JJ murine) (NNS models))
        (PP (IN of)
          (NP (NNP SLE))))
      (VP (VBP manifest)
        (NP
          (NP (DT a) (JJ wide) (NN range))
          (PP (IN of)
            (NP (JJ immunological) (NNS abnormalities))))))
    (. .)))

(ROOT
  (S
    (NP
      (NP (DT The)
        (ADJP (RBS most) (JJ pervasive)))
      (PP (IN of)
        (NP (DT these))))
    (VP (VBP include)
      (NP
        (NP (DT the) (NN generation))
        (PP (IN of)
          (NP (JJ pathogenic) (NNS autoantibodies)))))
    (. .)))

(ROOT
  (S
    (PP (IN In)
      (NP (DT this) (NN regard)))
    (, ,)
    (NP
      (NP (CD 98) (NN %))
      (PP (IN of)
        (NP (JJ human) (NNP SLE) (NNS patients))))
    (VP (VBP possess)
      (SBAR
        (S
          (NP
            (NP (NN antinuclear) (NNS antibodies))
            (CC and)
            (NP
              (NP
                (QP (CD 50) (TO to) (CD 80))
                (NN %))
              (PP (IN of)
                (NP (DT these)))))
          (VP (VBP have)
            (S
              (NP
                (NP (JJ anti-double-stranded) (NN DNA) (NNS antibodies))
                (, ,)
                (NP
                  (NP (DT the) (NN result))
                  (PP (IN of)
                    (NP (NNP unchecked) (NNP B) (JJ lymphocyte) (NN activation)
                      (CC and)
                      (NN antibody) (NN production))))
                (, ,))
              (ADJP (RB probably) (JJ due)
                (PP (TO to)
                  (NP (JJ uncontrolled) (NNP T) (NN cell) (NNS hyper-responsiveness)))))))))
    (. .)))

(ROOT
  (S
    (NP (DT Both) (JJ Th1)
      (CC and)
      (JJ Th2) (NNS responses))
    (VP (VBP are)
      (ADJP (JJ elevated))
      (, ,)
      (SBAR (IN as)
        (S
          (VP (VBN demonstrated)
            (PP (IN by)
              (NP
                (NP
                  (NP (DT the) (NN upregulation))
                  (PP (IN of)
                    (ADJP
                      (ADJP (RB proinflammatory) (JJ cytokines))
                      (, ,)
                      (ADJP
                        (ADVP (RB notably))
                        (JJ IFN-γ))
                      (, ,)
                      (ADJP (JJ IL-6))
                      (, ,)
                      (ADJP (JJ IL-12))
                      (, ,)
                      (CC and)
                      (ADJP (JJ IL-10)))))
                (, ,)
                (CONJP (RB as) (RB well) (IN as))
                (NP (NNP T) (JJ cell-dependent) (JJ autoantibody) (NN production))))))))
    (. .)))

(ROOT
  (S
    (ADVP (RB Interestingly))
    (, ,)
    (NP (DT these) (NNP T)
      (CC and)
      (NNP B) (NNP lymphocyte) (NNS abnormalities))
    (VP (VBP have)
      (VP (VBN been)
        (VP (VBN attributed) (, ,)
          (ADVP
            (ADVP (IN at) (JJS least))
            (RB partly))
          (, ,)
          (PP (TO to)
            (NP
              (NP (JJ defective) (NN production)
                (CC and)
                (NN function))
              (PP (IN of)
                (NP (NNP TGF-β) (NNP -LSB-) (CD 12,66) (NNS -RSB-))))))))
    (. .)))

(ROOT
  (S
    (PP (IN In)
      (NP
        (NP (NN contrast))
        (PP (TO to)
          (NP (JJ strong) (NNS suspicions)))))
    (, ,)
    (NP (JJ few) (NNS data))
    (ADVP (RB yet))
    (VP (VBP exist)
      (ADVP (RB as)
        (PP (TO to)
          (SBAR (IN whether)
            (S
              (NP
                (NP (DT the) (JJ uncontrolled) (NN T)
                  (CC and)
                  (NN B) (NN cell) (NN activation))
                (CC and)
                (NP
                  (NP (NNS pathogenesis))
                  (PP (IN in)
                    (NP (NNP SLE)))))
              (VP (MD can)
                (VP (VB be)
                  (VP (VBN attributed)
                    (PP (TO to)
                      (NP
                        (NP (DT a) (NN deficiency))
                        (PP (IN in)
                          (NP (NNP CD4) (NNP +) (NNP CD25) (NNP +) (JJ regulatory) (NN T) (NNS cells)))))))))))))
    (. .)))

(ROOT
  (S
    (PP (IN In)
      (NP (DT this) (NN regard)))
    (, ,)
    (S
      (NP (CD one) (NN study))
      (VP (VBD indicated)
        (SBAR (IN that)
          (S
            (NP (NNP CD4) (NNP +) (NNP CD25) (NNP +) (NNP T) (NNS cells))
            (VP (VBD were)
              (ADVP (RB significantly))
              (VP (VBN decreased)
                (PP (IN in)
                  (NP
                    (NP (NNS patients))
                    (PP (IN with)
                      (NP (JJ active) (NNP SLE)))))
                (PP (IN in)
                  (NP (NN comparison)))
                (PP (IN with)
                  (NP (JJ normal) (NNS subjects)
                    (CC and)
                    (NNS patients)))
                (PP (IN with)
                  (NP
                    (NP (DT an) (JJ inactive) (NN stage))
                    (PP (IN of)
                      (NP
                        (NP (DT the) (NN disease))
                        (VP (VBG -LSB-)
                          (NP
                            (QP (CD 67) (CD -RSB-))))))))))))))
    (, ,)
    (CC and)
    (S
      (PP (IN in)
        (NP (DT another) (JJ recent) (NN study)
          (QP (CD -LSB-) (CD 68))))
      (NP (NNP -RSB-) (NNP Treg))
      (VP (VBD were)
        (VP (VBN reported)
          (S
            (VP (TO to)
              (VP (VB be)
                (ADJP (JJ abnormal)
                  (PP (IN in)
                    (NP
                      (NP (NN number) (, ,) (NN phenotype) (, ,)
                        (CC and)
                        (NN function))
                      (PP (IN in)
                        (NP (NNS patients))))))
                (PP (IN with)
                  (NP (JJ active) (NNP SLE)))))))))
    (. .)))

(ROOT
  (S
    (ADVP (RB However))
    (, ,)
    (NP
      (NP (DT the) (JJ exact) (NN role))
      (PP (IN of)
        (NP
          (NP (DT the) (VBN decreased) (NNP CD4) (NNP +) (NNP CD25) (NNP +))
          (VP (VBG Treg)
            (NP (NNS levels))
            (PP (IN in)
              (NP
                (NP (DT the) (NNS pathogenesis))
                (PP (IN of)
                  (NP (NNP SLE)))))))))
    (VP (VBZ awaits)
      (NP
        (NP (NN demonstration))
        (PP (IN of)
          (NP
            (NP (DT a) (JJ significant) (NN correlation))
            (PP (IN between)
              (NP
                (NP
                  (NP (DT the) (NNS levels))
                  (PP (IN of)
                    (NP (NNP CD4) (NNP +) (NNP CD25) (NNP +) (NNP Treg))))
                (CC and)
                (NP
                  (NP (JJ inactive) (NN disease)
                    (CC or)
                    (JJ flare) (NN activity) (NNS -LSB-))
                  (NP (CD 69) (NNS -RSB-)))))))))
    (. .)))

(ROOT
  (S
    (PP (IN In)
      (NP
        (NP (JJ rheumatoid) (NN arthritis))
        (PRN (-LRB- -LRB-)
          (NP (NNP RA))
          (-RRB- -RRB-))))
    (, ,)
    (NP
      (NP (DT the) (NN relationship))
      (PP (IN between)
        (NP
          (NP (NNP CD4) (NNP +) (NNP CD25) (NNP +) (NNP Treg))
          (CC and)
          (NP
            (NP (NN Th1-dependent) (NNS pathogenesis))
            (PP (IN of)
              (NP (DT the) (NN disease)))))))
    (ADVP (RB also))
    (VP (VBZ remains)
      (PP (IN under)
        (NP (NN study))))
    (. .)))

(ROOT
  (S
    (NP (PRP It))
    (VP (VBD was)
      (ADVP (RB recently))
      (VP (VBN suggested)
        (NP
          (QP (CD -LSB-) (CD 70))
          (NNS -RSB-))
        (SBAR (IN that)
          (S
            (NP
              (NP (DT no) (JJ significant) (NN difference))
              (PP (IN in)
                (NP (JJ suppressive) (NN activity))))
            (VP (VBD was)
              (VP (VBN found)
                (PP (IN between)
                  (NP (NNP CD4) (NNP +) (NNP CD25) (NNP +) (NNP T) (NNS cells)))
                (PP (IN from)
                  (NP
                    (NP (JJ peripheral) (NN blood))
                    (PP (IN of)
                      (NP
                        (NP (NNP RA) (NNS patients))
                        (CC and)
                        (NP (JJ healthy) (NN control) (NNS subjects))))))
                (, ,)
                (SBAR (IN although)
                  (S
                    (NP (DT the) (NNS numbers))
                    (VP (MD may)
                      (VP (VB be)
                        (NP (JJR less) (JJ -LSB-) (CD 25) (NN -RSB-))))))))))))
    (. .)))

(ROOT
  (S
    (ADVP (RB Nonetheless))
    (, ,)
    (NP
      (NP (NNP CD4) (NNP +) (NNP CD25) (NNP +) (NNP T) (NNS cells))
      (PP (IN from)
        (NP (JJ synovial) (NN fluid))))
    (ADVP (RB reportedly))
    (VP (VBD had)
      (NP (DT a)
        (ADJP (RB significantly) (JJR higher))
        (NN suppressive) (NN activity))
      (PP (IN than)
        (NP
          (NP (DT those))
          (PP (IN in)
            (NP
              (NP (JJ peripheral) (NN blood))
              (PP (IN of)
                (NP (NNP RA) (NNS patients))))))))
    (. .)))

(ROOT
  (S
    (ADVP (RB Notably))
    (, ,)
    (PP (IN despite)
      (NP
        (NP (DT the) (NN presence))
        (PP (IN of)
          (NP
            (NP (DT these)
              (ADJP (RB highly) (JJ functional))
              (NN Treg))
            (PP (IN in)
              (NP (JJ synovial) (NN fluid)))))))
    (, ,)
    (NP (EX there))
    (VP (VBD was)
      (ADVP (RB still))
      (NP
        (NP (JJ ongoing) (NN inflammation))
        (PP (IN in)
          (NP (DT the) (NNS joints))))
      (, ,)
      (S
        (VP (VBG indicating)
          (NP
            (NP (DT the) (JJ complex) (NN picture))
            (PP (IN of)
              (NP
                (NP (NNP RA) (NNS pathogenesis))
                (, ,)
                (SBAR
                  (WHNP (WDT which))
                  (S
                    (VP (MD might)
                      (VP (VB reflect)
                        (NP
                          (NP (DT a) (JJ prominent) (NN imbalance))
                          (PP (IN between)
                            (NP (JJ regulatory)
                              (CC and)
                              (JJ inflammatory) (NNS checkpoints))))))))))))))
    (. .)))

(ROOT
  (SINV
    (PP (IN In)
      (NP
        (NP (DT an) (JJ encouraging) (JJ experimental) (NN therapy) (NN study))
        (, ,)
        (NP
          (NP (NNS patients))
          (PP (IN with)
            (NP (NNP RA)))
          (SBAR
            (WHNP (WP who))
            (S
              (VP (VBD were)
                (VP (VBN treated)
                  (PP (IN for)
                    (NP (CD 6) (NNS months)))
                  (PP (IN with)
                    (NP
                      (NP (JJ oral) (NNS dnaJP1))
                      (, ,)
                      (NP
                        (NP (DT a) (NN peptide))
                        (SBAR
                          (WHNP (WDT that))
                          (S
                            (VP (VBZ induces)
                              (NP
                                (NP (JJ proinflammatory) (NNP T) (NN cell) (NNS responses))
                                (PP (IN in)
                                  (NP
                                    (ADJP (JJ naive) (JJ RA))
                                    (NNS patients)))))))))))))))
        (, ,)))
    (VP (VBD manifested)
      (NP (VBN increased) (NNS Foxp3)))
    (NP
      (NP (NNP +) (NNP CD4) (NNP +) (NNP CD25) (NNP +) (NNP T) (NNS cells))
      (, ,)
      (VP (VBG suggesting)
        (SBAR (IN that)
          (S
            (NP
              (NP (DT the) (NN treatment))
              (VP (VBN induced)
                (NP
                  (NP
                    (NP (DT the) (NN emergence))
                    (PRN (-LRB- -LRB-)
                      (NP (NN enhancement))
                      (-RRB- -RRB-)))
                  (PP (IN of)
                    (NP (NNP T) (NNS cells))))
                (PP (IN with)
                  (NP (DT the) (JJ regulatory) (NN phenotype)))))
            (VP (VBZ -LSB-)
              (NP (CD 71) (NNS -RSB-)))))))
    (. .)))

(ROOT
  (S
    (PP (IN In)
      (ADJP (JJ short)))
    (, ,)
    (PP (IN despite)
      (NP
        (NP (DT the) (JJ complex) (NN picture))
        (PP (IN of)
          (NP
            (NP (NNP Treg))
            (PP (IN in)
              (NP (NN autoimmunity)))))))
    (, ,)
    (NP (PRP it))
    (VP (MD can)
      (VP (VB be)
        (VP (VBN envisioned)
          (SBAR (IN that)
            (S
              (NP (PRP it))
              (VP (MD will)
                (VP (VB become)
                  (ADJP (JJ feasible)
                    (S
                      (VP (TO to)
                        (VP (VB manipulate)
                          (NP (JJ regulatory) (NNP T) (NNS cells))
                          (PP (IN for)
                            (NP (JJ therapeutic) (NN benefit))))))))))))))
    (. .)))

(ROOT
  (S
    (PP (IN With)
      (NP (JJ continued) (NNS efforts)))
    (, ,)
    (NP
      (NP (DT a) (JJR better) (NN understanding))
      (CC and)
      (NP
        (ADJP (RBR more) (JJ advanced))
        (NNS techniques)))
    (VP (MD will)
      (VP (VB emerge)
        (PP (IN for)
          (NP
            (NP (DT the) (JJ induction) (NN and/or) (NN expansion))
            (PP (IN of)
              (NP (NNP Treg)))))
        (S
          (VP (TO to)
            (VP (VB enhance)
              (NP (PRP$ their) (NN role))
              (PP (IN in)
                (NP (NN autoimmunity) (, ,) (NN allergy) (, ,)
                  (CC and)
                  (NN graft) (NN rejection))))))))
    (. .)))

(ROOT
  (S
    (S
      (NP
        (NP (NNP Conclusion) (NNP Innate))
        (CC and)
        (NP (JJ adaptive) (JJ immune) (NNS responses)))
      (VP (VBP are)
        (ADJP (JJ essential)
          (S
            (VP (TO to)
              (VP (VB protect)
                (NP (DT the) (NN host))
                (PP (IN from)
                  (NP
                    (NP (DT a) (NN plethora))
                    (PP (IN of)
                      (NP
                        (ADJP (RB potentially) (JJ pathogenic))
                        (NNS microorganisms)))))))))))
    (, ,)
    (CC but)
    (S
      (NP (NNS countermeasures)
        (S
          (VP (TO to)
            (VP (VB prevent)
              (NP
                (NP (NN reactivity))
                (PP (IN of)
                  (NP (NN self))))))))
      (VP (VBP are)
        (ADJP (RB equally) (JJ essential))))
    (. .)))

(ROOT
  (S
    (S
      (SBAR (IN Although)
        (S
          (NP
            (NP (NN protection))
            (PP (IN against)
              (NP (JJ self-recognition-induced) (NN autoimmunity))))
          (VP (VBZ is)
            (VP (VBN accomplished)
              (PP (IN in)
                (NP (JJ large) (NN part)))
              (PP (IN by)
                (NP
                  (NP (DT the) (JJ central) (NN deletion))
                  (PP (IN of)
                    (NP (JJ autoreactive) (NNP T) (NNS cells)))))
              (PP (IN during)
                (NP (JJ intrathymic) (NN development)))))))
      (, ,)
      (NP (DT this) (NN process))
      (VP (VBZ is) (RB not)
        (ADJP (JJ perfect))))
    (CC and)
    (S
      (NP (JJ self-reactive) (NNS escapees))
      (VP (MD can)
        (VP (VB wreak)
          (NP (NN havoc))
          (PP (IN on)
            (NP (DT the) (JJ immune) (NN system))))))
    (. .)))

(ROOT
  (S
    (ADVP (RB However))
    (, ,)
    (PP (IN among)
      (NP (DT the) (NN backup)))
    (NP
      (NP (NNS pathways))
      (PP (IN in)
        (NP (DT the) (NN periphery)
          (S
            (VP (TO to)
              (VP (VB protect)
                (NP (PRP us))
                (PP (IN from)
                  (NP (NN self-destruction)))))))))
    (VP (VBP are)
      (NP
        (NP (NN deletion))
        (, ,)
        (NP (NN anergy))
        (, ,)
        (NP (NN ignorance))
        (, ,)
        (CC and)
        (NP (JJ active) (NN suppression))))
    (. .)))

(ROOT
  (S
    (PP (IN Among)
      (NP (DT these)))
    (, ,)
    (NP (JJ current) (NN interest))
    (VP (VBZ has)
      (VP (VBN zeroed)
        (PP (IN in) (IN on)
          (NP
            (NP (NNP CD4) (NNP +) (NNP CD25) (NNP +))
            (NP
              (NP (JJ regulatory) (NNP T) (NNS cells))
              (, ,)
              (SBAR
                (WHNP (WDT which))
                (S
                  (VP (MD can)
                    (ADVP (RB profoundly))
                    (VP (VB suppress)
                      (NP
                        (NP (NNP responder) (NNP T) (NN cell) (NN proliferation))
                        (CC and)
                        (NP (NNS cytokines)))
                      (PP (IN in)
                        (UCP
                          (ADJP (NN vitro))
                          (CC and)
                          (PP (IN in)
                            (NP (NN vivo))))))))))))))
    (. .)))

(ROOT
  (S
    (S
      (ADVP (RB Originally))
      (VP (VBN considered)
        (NP
          (NP (DT an) (JJ exclusive) (NN product))
          (PP (IN of)
            (NP (DT the) (NNS thymus))))))
    (, ,)
    (NP (JJ important) (JJ new) (NNS data))
    (VP (VBP indicate)
      (SBAR (IN that)
        (S
          (NP (DT these) (NNS cells))
          (VP (MD can)
            (VP (VB be)
              (VP
                (VP (VBN generated)
                  (PP (IN from)
                    (NP (JJ peripheral) (NNP CD4) (NNP +) (NNP T) (NNS cells))))
                (CC and)
                (VP (VBN expanded)
                  (PP (IN for)
                    (NP (NN delivery)))
                  (PP (IN as)
                    (NP (DT a) (JJ cellular) (JJ therapeutic) (NN strategy))))))))))
    (. .)))

(ROOT
  (S
    (NP
      (NP (NNPS Opportunities))
      (SBAR
        (S
          (VP (TO to)
            (VP (VB use)
              (NP (NNP suppressor) (NNP T) (NN cell) (NNS populations))
              (PP (IN in)
                (NP
                  (NP (DT the) (NN treatment))
                  (PP (IN of)
                    (S
                      (VP (VBG debilitating)
                        (NP
                          (NP (JJ autoimmune) (NNS diseases))
                          (, ,)
                          (NP (NN allergy))
                          (, ,)
                          (NP (JJ chronic) (JJ infectious) (NNS diseases))
                          (, ,)
                          (CC and)
                          (NP (NN transplant) (NN rejection)))))))))))))
    (VP (VBP are)
      (ADVP (RB no) (RB longer))
      (NP
        (NP (DT a) (NN dream))
        (PP (IN of)
          (NP
            (NP (DT the) (NN future))
            (SBAR (CC but)
              (S
                (VP (VBP are)
                  (NP (DT an) (VBG emerging) (NN reality)))))))))
    (. .)))

(ROOT
  (S
    (ADVP (RB Moreover))
    (, ,)
    (SBAR (IN as)
      (S
        (NP (PRP we))
        (VP (VB illuminate)
          (NP
            (NP (DT the) (NNS mechanisms))
            (PP (IN of)
              (NP
                (NP (NN regulation))
                (PP (IN of)
                  (NP (DT these) (NNP Treg)))))))))
    (, ,)
    (NP (PRP it))
    (VP (MD might)
      (ADVP (RB also))
      (VP (VB become)
        (NP
          (ADJP (JJ feasible)
            (S
              (VP (TO to)
                (VP
                  (VP (VB diminish) (, ,)
                    (CONJP (RB rather) (IN than))
                    (VB augment))
                  (, ,)
                  (NP (PRP$ their) (NN numbers/activity)
                    (S
                      (VP (TO to)
                        (VP (VB promote)
                          (NP (NN tumor) (NN rejection)
                            (CC and)
                            (NN vaccine) (NNS responses))))))))))
          (NN and/or)
          (S
            (VP (TO to)
              (VP (VB reverse)
                (NP (JJ immunodeficiency) (NNS diseases))))))))
    (. .)))

(ROOT
  (NP
    (NP
      (NP
        (NP
          (NP (NNP Abbreviations) (NNP APCs))
          (SBAR
            (S
              (VP (SYM =)
                (NP (JJ antigen-presenting) (NNS cells))))))
        (: ;)
        (NP
          (NP (NNP IFN))
          (SBAR
            (S
              (VP (SYM =)
                (NP (NN interferon))))))
        (: ;)
        (NP
          (NP (NNP IL))
          (SBAR
            (S
              (VP (SYM =)
                (NP (NN interleukin))))))
        (: ;)
        (NP
          (NP (NNP LAP))
          (SBAR
            (S
              (VP (SYM =)
                (NP (JJ latency-associated) (NN peptide))))))
        (: ;)
        (NP
          (NP (NNP RA))
          (SBAR
            (S
              (VP (SYM =)
                (NP (JJ rheumatoid) (NN arthritis))))))
        (: ;)
        (NP
          (NP (NNP SLE))
          (SBAR
            (S
              (VP (SYM =)
                (NP (JJ systemic) (NN lupus) (NNS erythematosus))))))
        (: ;)
        (NP
          (NP (NNP TβR))
          (SBAR
            (S
              (VP (SYM =)
                (NP (JJ TGF-β) (NN receptor))))))
        (: ;)
        (NP
          (NP (NNP TCR))
          (SBAR
            (S
              (VP (SYM =)
                (NP (JJ T-cell) (NN receptor))))))
        (: ;)
        (NP
          (NP (NNP TGF))
          (SBAR
            (S
              (VP (SYM =)
                (NP (JJ transforming) (NN growth) (NN factor))))))
        (: ;)
        (NP
          (NP (NNP Th) (NNP =) (NNP T))
          (NP (NN helper) (NN cell)))
        (: ;)
        (NP
          (NP (NNP Treg))
          (SBAR
            (S
              (VP (SYM =)
                (NP (JJ regulatory) (NNP T) (NN cell)))))))
      (PRN (-LRB- -LRB-) (PRP s) (-RRB- -RRB-)))
    (: ;)
    (NP
      (NP (NNP TSP))
      (SBAR
        (S
          (VP (SYM =)
            (NP (NN thrombospondin))))))
    (. .)))

(ROOT
  (S
    (NP
      (NP
        (NP (JJ Competing) (NNS interests))
        (NP (DT The) (NN author)))
      (PRN (-LRB- -LRB-) (PRP s) (-RRB- -RRB-)))
    (VP (VBP declare)
      (SBAR (IN that)
        (S
          (NP (PRP they))
          (VP (VBP have)
            (NP (DT no) (VBG competing) (NNS interests))))))
    (. .)))

(ROOT
  (S
    (NP (NNP Figure)
      (CC and)
      (NNP Table))
    (VP (VBZ captions)
      (NP
        (NP (NNP Figure) (CD 1))
        (: :)
        (S
          (NP (NNP Regulatory) (NNP T) (NNS cells))
          (VP (VB mediate)
            (NP
              (ADJP (JJ inflammatory)
                (CC and)
                (JJ immune))
              (NNS reactions))))))
    (. .)))

(ROOT
  (S
    (NP (NNP CD4) (NNP +) (NNP CD25) (NNP +) (NNP Treg))
    (VP (MD can)
      (VP (VB suppress)
        (NP
          (NP (NNP CD4) (NNP +) (NNP CD25))
          (: -)
          (NP
            (NP (NNP T) (NN cell) (NNS responses))
            (PP (TO to)
              (NP (NNS antigens)))))
        (PP (IN through)
          (NP
            (NP (DT a) (JJ contact-dependent) (, ,) (JJ antigen-nonspecific) (NN mechanism))
            (PP (VBG involving)
              (NP (NNP TGF-β)))))))
    (. .)))

(ROOT
  (NP
    (NP (NNP Treg) (NNP suppress) (NNP CD4) (NNP +) (NNP CD25))
    (: -)
    (NP (NN responder) (NN T) (NN cell) (NN proliferation)
      (CC and)
      (NN cytokine) (NN production))
    (, ,)
    (VP (VBG reining)
      (PP (IN in)
        (NP (JJ Th1) (NN and/or) (NNS Th2) (NN immunity))))
    (. .)))

(ROOT
  (S
    (PP (IN Without)
      (NP
        (NP (JJ adequate) (NN intercession))
        (PP (IN by)
          (NP (NNP Treg)))))
    (, ,)
    (NP
      (ADJP (JJ Th1) (: -)
        (CC or)
        (JJ Th2-dominated))
      (NNS responses))
    (VP (MD may)
      (VP (VB become)
        (ADJP (JJ pathogenic))))
    (. .)))

(ROOT
  (NP
    (NP (NNP Figure) (CD 2))
    (: :)
    (NP
      (NP (NNP Treg))
      (VP (VBN expanded)
        (PP (IN in)
          (NP
            (NP
              (ADJP (NN vitro) (NN suppress))
              (JJ allergen-induced) (NN asthma))
            (PP (IN in)
              (NP (NN vivo)))))))
    (. .)))

(ROOT
  (S
    (NP
      (NP (NNS Mice))
      (VP
        (VP (VBN sensitized)
          (S
            (VP (TO to)
              (VP (VB house)
                (NP
                  (NP (NN dust) (NN mite))
                  (PRN (-LRB- -LRB-)
                    (NP (NNP HDM))
                    (-RRB- -RRB-)))
                (PP (IN by)
                  (NP
                    (NP (JJ intraperitoneal)
                      (PRN (-LRB- -LRB-)
                        (NP (NN ip))
                        (-RRB- -RRB-))
                      (NN injection))
                    (PP (IN with)
                      (NP (NNP HDM)))))
                (PP (IN on)
                  (NP (NNS days) (CD 0)
                    (CC and)
                    (CD 7)))))))
        (CC and)
        (VP
          (ADVP (RB then))
          (VBN challenged)
          (PP (IN by)
            (NP
              (NP (JJ intratracheal)
                (PRN (-LRB- -LRB-)
                  (NP (PRP it))
                  (-RRB- -RRB-))
                (NN injection))
              (PP (IN on)
                (NP (NNS days) (CD 14)
                  (CC and)
                  (CD 21))))))))
    (VP (VBD were)
      (VP (VBN injected)
        (ADVP (RB intraperitoneally))
        (PP (IN on)
          (NP (NNS days) (CD 0)
            (CC and)
            (CD 14)))
        (PP (IN with)
          (NP (NNP Treg)))))
    (. .)))

(ROOT
  (S
    (PP
      (NP (CD Three) (NNS days))
      (IN after)
      (NP
        (NP (DT the) (JJ second) (JJ intratracheal) (NN challenge))
        (PP (IN with)
          (NP (NNP HDM)))))
    (, ,)
    (NP (DT the) (NNS lungs))
    (VP (VBD were)
      (VP (VBN assessed)
        (PP (IN for)
          (NP (NN histopathology)))
        (PP (IN by)
          (NP
            (NP (JJ periodic) (JJ acid) (NN Schiff))
            (VP (VBG staining)
              (PP (IN for)
                (NP
                  (NP (NNS mucopolysaccharides))
                  (PRN (-LRB- -LRB-)
                    (ADJP (JJ red))
                    (-RRB- -RRB-)))))))))
    (. .)))

(ROOT
  (S
    (NP
      (NP (JJ Inflammatory) (NN pathology)
        (CC and)
        (NN mucin) (NN obstruction))
      (PP (IN of)
        (NP (DT the) (NNS airways))))
    (VP (VBD were)
      (ADJP (RB strikingly) (JJ reduced)
        (PP (IN in)
          (NP
            (NP (NNS mice))
            (VP (VBG receiving)
              (S
                (VP (VBG Treg)
                  (NP
                    (QP (CD -LSB-) (CD 12))
                    (NNS -RSB-)))))))))
    (. .)))

